A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans.
| Member | Definition | Class |
|---|
| 1-octen-3-ol | An alkenyl alcohol with a structure based on a C8 unbranched chain with the hydroxy group at C-2 and unsaturation at C-1-C-2. It is a major volatile compound present in many mushrooms and fungi. | oct-1-en-3-ol |
| 1-phenazinecarboxylic acid | An aromatic carboxylic acid that is phenazine substituted at C-1 with a carboxy group. | phenazine-1-carboxylic acid |
| 2-methoxy-1,4-naphthoquinone | A naphthoquinone that is naphthalene-1,4-dione substituted by a methoxy group at position 2. It has been isolated from the roots of Rubia yunnanensis. | 2-methoxy-1,4-naphthoquinone |
| 2-methyl-4-isothiazolin-3-one | A 1,2-thazole that is 4-isothiazolin-3-one bearing a methyl group on the nitrogen atom. It is a powerful biocide and preservative and is the minor active ingredient in the commercial product Kathon(TM). | methylisothiazolinone |
| 3,3'-neotrehalosadiamine | An amino disaccharide consisting of alpha- and beta-D-kanosaminyl residues joined by a (1<->1)-linkage. | 3,3'-neotrehalosadiamine |
| 32,33,34,35-bacteriohopanetetrol | A hopanoid that is bacteriohopane carrying four hydroxy substituents at positions 32, 33, 34 and 35. | bacteriohopane-32,33,34,35-tetrol |
| 5-chloro-2-methyl-4-isothiazolin-3-one | A 1,2-thiazole that is 4-isothiazolin-3-one bearing a methyl group on the nitrogen atom and a chlorine at C-5. It is a powerful biocide and preservative and is the major active ingredient in the commercial product Kathon(TM). | chloromethylisothiazolinone |
| acetylspiramycin | A macrolide antibiotic produced by various Streptomyces species. | spiramycin II |
| acivicin | An L-alpha-amino acid that is L-alanine in which the methyl group is replaced by a (5S)-3-chloro-4,5-dihydro-1,2-oxazol-5-yl group. A glutamine analogue antimetabolite, it interferes with glutamate metabolism and several glutamate-dependent synthetic enzymes. It is obtained as a fermentation product of Streptomyces sviceus bacteria. | acivicin |
| aclacinomycin | An anthracycline that is aklavinone having an alpha-L-rhodosaminyl residue attached at position 4 via a glycosidic linkage. | aclacinomycin T zwitterion; aclacinomycin T |
| aclacinomycin | A zwitterion obtained by transfer of a proton from the 5-hydroxy to the tertiary amino group of aclacinomycin T. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.). | aclacinomycin T zwitterion; aclacinomycin T |
| aclarubicin | An anthracycline antibiotic that is produced by Streptomyces galilaeus and also has potent antineoplastic activity. | aclacinomycin A zwitterion; aclacinomycin A |
| aclarubicin | A zwitterion obtained by transfer of a proton from the 5-hydroxy to the tertiary amino group of aclacinomycin A. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.). | aclacinomycin A zwitterion; aclacinomycin A |
| allyl isothiocyanate | An isothiocyanate with the formula CH2=CHCH2N=C=S. A colorless oil with boiling point 152degreeC, it is responsible for the pungent taste of mustard, horseradish, and wasabi. | allyl isothiocyanate |
| alpha phellandrene | One of a pair of phellandrene cyclic monoterpene double-bond isomers in which both double bonds are endocyclic (cf. alpha-phellandrene, where one of them is exocyclic). | alpha-phellandrene |
| amikacin | An amino cyclitol glycoside that is kanamycin A acylated at the N-1 position by a 4-amino-2-hydroxybutyryl group. | amikacin |
| anisomycin | An antibiotic isolated from various Streptomyces species. It interferes with protein and DNA synthesis by inhibiting peptidyl transferase or the 80S ribosome system. | (-)-anisomycin |
| anticapsin | An L-alpha-amino acid zwitterion obtained by transfer of a proton from the carboxy to the amino group of anticapsin; major species at pH 7.3. | anticapsin zwitterion; anticapsin |
| anticapsin | An alanine derivative that is L-alanine bearing a 5-oxo-7-oxabicyclo[4.1.0]hept-2-yl substituent at position 3. | anticapsin zwitterion; anticapsin |
| antofine | An organic heteropentacyclic compound that is (13aR)-9,11,12,13,13a,14-hexahydrodibenzo[f,h]pyrrolo[1,2-b]isoquinoline substituted at positions 2, 3 and 6 by methoxy groups. It is an alkaloid produced by relatives of the milkweed family and exhibits antiviral, anti-inflammatory, antiadipogenic and antitumorigenic activities. | (-)-antofine |
| aphidicolin | A tetracyclic diterpenoid that has an tetradecahydro-8,11a-methanocyclohepta[a]naphthalene skeleton with two hydroxymethyl substituents at positions 4 and 9, two methyl substituents at positions 4 and 11b and two hydroxy substituents at positions 3 and 9. An antibiotic with antiviral and antimitotical properties. Aphidicolin is a reversible inhibitor of eukaryotic nuclear DNA replication. | aphidicolin |
| apramycin | An aminoglycoside that is 2-deoxystreptamine that is substituted on the oxygen at position 4 by an (8R)-2-amino-8-O-(4-amino-4-deoxy-alpha-D-glucopyranosyl)-2,3,7-trideoxy-7-(methylamino)-D-glycero-alpha-D-allo-octodialdo-1,5:8,4-dipyranos-1-yl) group. | apramycin |
| arbekacin | A kanamycin that is kanamycin B bearing an N-(2S)-4-amino-2-hydroxybutyryl group on the aminocyclitol ring. | arbekacin |
| arenaemycin e | A sesquiterpene lactone that is isolated from several Streptomyces species and exhibits antibiotic activity. | pentalenolactone |
| arisugacin | An organic heterotetracyclic compound that is 4a,12a-dihydroxy-4,4,6a,12b-tetramethyl-4a,6,6a,12,12a,12b-hexahydro-4H,11H-benzo[f]pyrano[4,3-b]chromene-1,11(5H)-dione substituted by 3,4-dimethoxyphenyl group at position 9 (the 4aR,6aR,12aS,12bS steroisomer). Isolated from the culture broth of Penicillium, it acts as a selective inhibitor of acetylcholinesterase. | arisugacin A |
| asukamycin | A polyketide that is a member of the manumycin family of antibiotics and exhibits strong antibacterial, antifungal, and antineoplastic activities. Isolated from from the actinomycete bacterium Streptomyces nodosus subsp. asukaensis. | asukamycin |
| avibactam | A member of the class of azabicycloalkanes that is (2S,5R)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamide in which the amino hydrogen at position 6 is replaced by a sulfooxy group. Used (in the form of its sodium salt) in combination with ceftazidime pentahydrate for the treatment of complicated urinary tract infections including pyelonephritis. | avibactam |
| avilamycin a | An oligosaccharide derivative that is produced by Streptomyces viridochromogenes and exhibits antibiotic properties. | avilamycin A |
| ay 25545 | A C-glycosylated naphthoisochromene derivative obtained from Streptomyces ravidus; exhibits antibiotic and anticancer properties. | ravidomycin |
| azaserine | A carboxylic ester resulting from the formal condensation of the carboxy group of diazoacetic acid with the alcoholic hydroxy group of L-serine. An antibiotic produced by a Streptomyces species. | azaserine |
| baci-im | A homodetic cyclic peptide consisting of (4R)-2-[(1S,2S)-1-amino-2-methylbutyl]-4,5-dihydro-1,3-thiazole-4-carboxylic acid attached head-to-tail to L-leucyl,D-glutamyl, L-lysyl, D-ornityl, L-isoleucyl, D-phenylalanyl, L-histidyl. D-aspartyl and L-asparaginyl residues coupled in sequence and cyclised by condensation of the side-chain amino group of the L-lysyl residue with the C-terminal carboxylic acid group. It is the major component of bacitracin. | bacitracin A zwitterion; bacitracin A |
| bacillaene | A polyene antibiotic obtained from Bacillus subtilis 168 that is active against a broad spectrum of bacteria. It is notoriously unstable. | bacillaene |
| benzoylmetronidazole | A benzoate ester resulting from the formal condensation of benzoic acid with the hydroxy group of metronidazole. | metronidazole benzoate |
| bialaphos | A tripeptide comprising one L-phosphinothricyl and two L-alanyl units joined in sequence. | bilanafos |
| bisdechlorogeodin | | bisdechlorogeodin |
| borrelidin | A macrolide that is isolated from several Streptomyces species and displays antibiotic, antineoplastic and antimalarial properties. | borrelidin |
| brartemicin | A glycosyl glycoside derivative that consists of alpha,alpha-trehalose substituted at positions 6 and 6' by O-2,4-dihydroxy-6-methylbenzoyl groups. It is isolated from the culture broth of actinomycete, Nonomuraea, and has antitumor activity. | brartemicin |
| brasilicardin a | A diterpenoid antibiotic isolated from the culture broth of Nocardia brasiliensis IFM0406. It exhibits antitumour and strong immunosuppressive activity. | brasilicardin A |
| bromodiphenhydramine | A tertiary amino compound that is the 4-bromobenzhydryl ether of 2-(dimethylamino)ethanol. An antihistamine with antimicrobial properties, it is used in the control of cutaneous allergies. | bromazine |
| cannabidiol | An cannabinoid that is cyclohexene which is substituted by a methyl group at position 1, a 2,6-dihydroxy-4-pentylphenyl group at position 3, and a prop-1-en-2-yl group at position 4. | cannabidiol |
| carvacrol | A phenol that is a natural monoterpene derivative of cymene. An inhibitor of bacterial growth, it is used as a food additive. Potent activator of the human ion channels transient receptor potential V3 (TRPV3) and A1 (TRPA1). | carvacrol |
| cathestatin b | A carboxamide obtained by the formal condensation of the carboxylic group of oxirane-2,3-dicarboxylic acid with the amino group of N-(4-aminobutyl)-L-tyrosinamide (the 2S,3S stereoisomer). An antibiotic isolated from the fermentation broth of Penicillium citrinum, it acts as a potent inhibitor of cysteine protease. | cathestatin B |
| cefluprenam | A fourth-generation cephalosporin antibiotic having (1E)-3-[(2-amino-2-oxoethyl)(ethyl)methylazaniumyl]prop-1-en-1-yl and {(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-[(fluoromethoxy)imino]acetyl}amino side groups located at positions 3 and 7 respectively. | cefluprenam |
| cefmetazole sodium | An organic sodium salt that is the sodium salt of cefmetazole. | cefmetazole sodium |
| ceftobiprole | A fifth-generation cephalosporin antibiotic having (E)-[(3'R)-2-oxo[1,3'-bipyrrolidin]-3-ylidene]methyl and [(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(hydroxyimino)acetyl]amino side groups located at positions 3 and 7 respectively; developed for the treatment of hospital-acquired pneumonia (HAP, excluding ventilator-associated pneumonia, VAP) and community-acquired pneumonia (CAP). | ceftobiprole |
| cephaloglycin | A cephalosporin antibiotic containing at the 7beta-position of the cephem skeleton an (R)-amino(phenyl)acetamido group. | cefaloglycin |
| cephalothin | A semisynthetic, first-generation cephalosporin antibiotic with acetoxymethyl and (2-thienylacetyl)nitrilo moieties at positions 3 and 7, respectively, of the core structure. Administered parenterally during surgery and to treat a wide spectrum of blood infections. | cefalotin |
| cerulenin | An epoxydodecadienamide isolated from several species, including Acremonium, Acrocylindrum and Helicoceras. It inhibits the biosynthesis of several lipids by interfering with enzyme function. | cerulenin |
| chir 090 | An L-threonine derivative obtained by formal condensation of the carboxy group of 4-({4-[(morpholin-4-yl)methyl]phenyl}ethynyl)benzoic acid with the amino group of N-hydroxy-L-threoninamide. | CHIR-090 |
| chloramphenicol | An organochlorine compound that is dichloro-substituted acetamide containing a nitrobenzene ring, an amide bond and two alcohol functions. | chloramphenicol |
| chlorocresol | A hydroxytoluene that is 3-methylphenol which is substituted by a chlorine at position 4. A ryanodine receptor agonist. | 4-chloro-m-cresol |
| chloroorienticin b | A glycopeptide that is isolated from Amycolatopsis orientalis. | chloroorienticin B |
| chuangxinmycin | A thiinoindole that is 3,5-dihydro-2H-thiino[4,3,2-cd]indole which is substituted at positions 2 and 3 by carboxy and methyl groups, respectively (the 2R,3S diastereoisomer). | (-)-chuangxinmycin |
| ciprofloxacin | A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively. | ciprofloxacin zwitterion; ciprofloxacin |
| citric acid, anhydrous | A tricarboxylic acid that is propane-1,2,3-tricarboxylic acid bearing a hydroxy substituent at position 2. It is an important metabolite in the pathway of all aerobic organisms. | citric acid |
| clavulanate potassium | A potassium salt having clavulanate as the counterion. It acts as a suicide inhibitor of bacterial beta-lactamase enzymes and has only weak anitbiotic activity when administered alone. However it can be used in combination with amoxicillin trihydrate (under the trade name Augmentin) for treatment of a variety of bacterial infections, where it prevents antibiotic inactivation by microbial lactamases. | potassium clavulanate |
| clioquinol | A monohydroxyquinoline that is quinolin-8-ol in which the hydrogens at positions 5 and 7 are replaced by chlorine and iodine, respectively. It has antibacterial and atifungal properties, and is used in creams for the treatment of skin infections. It has also been investigated as a chelator of copper and zinc ions for the possible treatment of Alzheimer's disease. | 5-chloro-7-iodoquinolin-8-ol |
| complestatin | A heterodetic cyclic peptide consisting of N-acylated trytophan, 3,5-dichloro-4-hydroxyphenylglycine, 4-hydroxyphenylglycine, 3,5-dichloro-4-hydroxyphenylglycyl, tyrosine and 4-hydroxyphenylglycine residues joined in sequence and in which the side-chain of the central 4-hydroxyphenylglycine residue is attached to the side-chain of the tryptophan via a C3-C6 bond and to the side-chain of the tyrosine via an ether bond from C5. It is isolated from the culture broth of Streptomyces and has anti-HIV-1 activity. | chloropeptin II; isocomplestatin |
| coumermycin | A hydroxycoumarin antibiotic that is obtained from Streptomyces rishiriensis and exhibits potent antibacterial and anticancer activity. | coumermycin A1 |
| cubebin | A lignan that consists of tetrahydrofuran-2-ol substituted by two 1,3-benzodioxol-5-ylmethyl groups at positions 3 and 4 respectively (the 2S,3R,4R stereoisomer). It is isolated from the leaves of Piper nigrum and exhibits analgesic, anti-inflammatory, antimicrobial and trypanocidal activities. | (-)-cubebin |
| cytotrienin a | A 21-membered macrocyclic lactam which contains three conjugated double bonds as part of the ring system. It acts as an apoptosis inducer in human leukemia HL-60 cells and is isolated from Streptomyces sp. | cytotrienin A |
| dalbavancin | A semisynthetic glycopeptide used for the treatment of acute bacterial skin and skin structure infections caused or suspected to be caused by susceptible isolates of designated Gram-positive microorganisms including MRSA. | dalbavancin |
| demycarosylturimycin h | A macrolide antibiotic produced by various Streptomyces species that is used to treat toxoplasmosis and various other infections of soft tissues. | spiramycin I |
| duramycin | A 19-membered heterodetic cyclic peptide that is isolated from Streptoverticillium cinnamoneus. It exhibits antiproliferative properties and induces apoptosis in tumour cells and has been used for treatment of cystic fibrosis. | lancovutide |
| elloramycin | A member of the class of tetracenomycins that is 8-demethyltetracenomycin C in which the hydroxyl hydrogens at position 8 and 10 a are replaced by a 2,3,4-tri-O-methyl-alpha-L-rhamnosyl and methyl groups respectively. | elloramycin A |
| embelin | A member of the class of dihydroxy-1,4-benzoquinones that is 2,5-dihydroxy-1,4-benzoquinone which is substituted by an undecyl group at position 3. Isolated from Lysimachia punctata and Embelia ribes, it exhibits antimicrobial, antineoplastic and inhibitory activity towards hepatitis C protease. | embelin |
| enniatin b | An enniatin obtained from formal cyclocondensation of three N-[(2R)-2-hydroxy-3-methylbutanoyl]-N-methyl-L-valine units. | enniatin B |
| enrofloxacin | A quinolinemonocarboxylic acid that is 1,4-dihydroquinoline-3-carboxylic acid substituted by an oxo group at position 4, a fluoro group at position 6, a cyclopropyl group at position 1 and a 4-ethylpiperazin-1-yl group at position 7. It is a veterinary antibacterial agent used for the treatment of pets. | enrofloxacin |
| epirubicin | An anthracycline that is the 4'-epi-isomer of doxorubicin. | 4'-epidoxorubicin |
| finafloxacin | A quinolone that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted at positions 1, 6, 7 and 8 by cyclopropyl, fluoro, hexahydropyrrolo[3,4-b][1,4]oxazin-6-yl and cyano groups respectively; an antibiotic used for treatment of acute otitis externa (swimmer's ear) caused by the bacteria Pseudomonas aeruginosa and Staphylococcus aureus. | finafloxacin |
| florfenicol | A carboxamide that is the N-dichloroacetyl derivative of (1R,2S)-2-amino-3-fluoro-1-[4-(methanesulfonyl)phenyl]propan-1-ol. A synthetic veterinary antibiotic that is used for treatment of bovine respiratory disease and foot rot; also used in aquaculture. | florfenicol |
| fosfomycin | A phosphonic acid having an (R,S)-1,2-epoxypropyl group attached to phosphorus. | fosfomycin |
| fosmidomycin | Propylphosphonic acid in which one of the hydrogens at position 3 is substituted by a formyl(hydroxy)amino group. An antibiotic obtained from Streptomyces lavendulae, it specifically inhibits DXP reductoisomerase (EC 1.1.1.267), a key enzyme in the non-mevalonate pathway of isoprenoid biosynthesis. | fosmidomycin |
| fr 901464 | A spiro-epoxide with potent anticancer activity that lowers the mRNA levels of oncogenes and tumour supressor genes. It is isolated from Pseudomonas sp. no.2663. | FR901464 |
| fraxetin | A hydroxycoumarin that is 6-methoxycoumarin in which the hydrogens at positions 7 and 8 have been replaced by hydroxy groups. | fraxetin |
| fumagillin | A meroterpenoid resulting from the formal condensation of the hydroxy group of fumagillol with the carboxylic acid group of (all-E)-deca-2,4,6,8-tetraenedioic acid. Originally isolated from the fungus Aspergillus fumigatus, it is used for the control of Nosema infection in honey bees. | fumagillin |
| fumagillol | A sesquiterpenoid with antimicrobial properties. | fumagillol |
| furanomycin | A non-proteinogenic L-alpha-amino acid that is L-alanine in which the methyl group is replaced by a (2R,5S)-5-methyl-2,5-dihydrofuran-2-yl moiety. | furanomycin |
| galangin | A 7-hydroxyflavonol with additional hydroxy groups at positions 3 and 5 respectively; a growth inhibitor of breast tumor cells. | galangin |
| gatifloxacin | A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes. | gatifloxacin |
| geldanamycin | An ansamycin consisting of a 19-membered macrocyle incorporating a benzoquinone ring and a lactam functionality. It shows antimicrobial activity against many Gram-positive and some Gram-negative bacteria. | geldanamycin |
| gemifloxacin | A 1,4-dihydro-1,8-naphthyridine with a carboxy group at the 3-position, an oxo sustituent at the 4-position, a fluoro substituent at the 5-position and a substituted pyrrolin-1-yl group at the 7-position. | gemifloxacin |
| gemifloxacin mesylate | The mesylate salt of gemifloxacin. | gemifloxacin mesylate |
| germacrone | A germacrane sesquiterpenoid that has formula C15H22O. It is a natural product found in traditional medicinal plants of the family Zingiberaceae. The compound exhibits a range of pharmacological activities including anti-inflammatory, anticancer, antiviral, anti-androgenic, antioxidant, antimicrobial, antifungal, neuroprotective and insecticidal activities. | (E,E)-germacrone |
| hadacidin | A monocarboxylic acid that is N-hydroxyglycine in which the hydrogen attached to the nitrogen is replaced by a formyl group. It was originally isolated from cultures of Penicillium frequentans. | hadacidin |
| herbimycin | A 19-membered macrocyle incorporating a benzoquinone ring and a lactam functionality. It is an ansamycin antibiotic that induces apoptosis and displays antitumour effects. | herbimycin |
| hexamidine | A polyether that is the bis(4-guanidinophenyl) ether of hexane-1,6-diol. | hexamidine |
| i-677 | An L-alpha-amino acid that is L-serine in which the hydroxy group at position 3 is converted to the corresponding 2-aminoethyl ether. An antimetabolic antibiotic obtained from Streptomyces reseoviridofuscus. | O-(2-aminoethyl)-L-serine |
| ilicicolin h | An aromatic ketone in which the ketone carbonyl group is attached to a (1R,2R,4aS,7S,8aR)-4,7-dimethyl-1-[(1E)-prop-1-en-1-yl]-1,2,4a,5,6,7,8,8a-octahydronaphthalen-2-yl group and a 4-hydroxy-5-(4-hydroxyphenyl)-2-oxo-1,2-dihydropyridin-3-yl group. Isolated from the from the "imperfect" fungus Cylindrocladium iliciola strain MFC-870. | ilicicolin H |
| imidazolidinyl urea | | imidurea |
| indolmycin | A member of the class of 1,3-oxazoles that is 1,3-oxazol-4(5H)-one which is substituted at the 2 and 5-pro-S positions by methylamino and [(1R)-1-(1H-indol-3-yl)ethyl] groups, respectively. | indolmycin |
| kalimantacin a | A fatty acid derivative isolated from the fermentation broth of Alcaligenes sp. YL-02632S. It is an antibiotic with antibacterial activity. | kalimantacin B |
| lactonamycin | An organic heterohexacyclic compound isolated from the culture broth of Streptomyces rishiriensis. It is an antibiotic with antibacterial activity. | lactonamycin |
| linalool | A monoterpenoid that is octa-1,6-diene substituted by methyl groups at positions 3 and 7 and a hydroxy group at position 3. It has been isolated from plants like Ocimum canum. | linalool |
| lincomycin | A carbohydrate-containing antibiotic produced by the actinomyces Streptomyces lincolnensis. | lincomycin |
| liriodenine | An oxoaporphine alkaloid that is 4,5,6,6a-tetradehydronoraporphin-7-one substituted by a methylenedioxy group across positions 1 and 2. It is isolated from Annona glabra and has been shown to exhibit antimicrobial and cytotoxic activities. | liriodenine |
| lomefloxacin | A fluoroquinolone antibiotic, used (generally as the hydrochloride salt) to treat bacterial infections including bronchitis and urinary tract infections. It is also used to prevent urinary tract infections prior to surgery. | lomefloxacin |
| lomefloxacin hydrochloride | The hydrochloride salt of lomefloxacin. It is administered by mouth to treat bacterial infections including bronchitis and urinary tract infections. It is also used topically as eye drops for the treatment of bacterial conjunctivitis, and as ear drops for the treatment of otitis externa and otitis media. | lomefloxacin hydrochloride |
| lupulon | A beta-bitter acid in which the acyl group is specified as 3-methylbutanoyl. | lupulone |
| ly 163892 | A synthetic "carba" analogue of cefaclor, with carbon replacing sulfur at position 1. Used to treat a wide range of infections caused by both gram-positive and gram-negative bacteria. | loracarbef zwitterion; loracarbef |
| mangostin | A member of the class of xanthones that is 9H-xanthene substituted by hydroxy group at positions 1, 3 and 6, a methoxy group at position 7, an oxo group at position 9 and prenyl groups at positions 2 and 8. Isolated from the stems of Cratoxylum cochinchinense, it exhibits antioxidant, antimicrobial and antitumour activities. | alpha-mangostin |
| manumycin | A polyketide with formula C31H38N2O7 initially isolated from Streptomyces parvulus as a result of a random screening program for farnesyl transferase (FTase) inhibitors. It is a natural product that exhibits anticancer and antibiotic properties. | manumycin A |
| marinopyrrole a | A member of the class of pyrroles that is 1'H-1,3'-bipyrrole substituted by four chloro groups at positions 4, 4', 5 and 5' and two 2-hydroxybenzoyl moieties at positions 2 and 2'. It is isolated from Streptomyces sp.CNQ-418 and exhibits cytotoxic and antibacterial activities. | (-)-marinopyrrole A |
| mastoparan | A member of the class of mastopyrans that is a 14-amino acid polypeptide comprising isoleucyl, asparaginyl, leucyl, lysyl, alanyl, leucyl, alanyl, alanyl, leucyl, alanyl, lysyl, lysyl, isoleucyl, and leucinamide residues coupled in sequence. It is the major active component of the venom of the vespid wasp, Vespula lewisii and causes degranulation of mast cells. | mastoparan |
| maytansine | An organic heterotetracyclic compound and 19-membered macrocyclic lactam antibiotic originally isolated from the Ethiopian shrub Maytenus serrata but also found in other Maytenus species. It exhibits cytotoxicity against many tumour cell lines. | maytansine |
| methylene blue | An organic chloride salt having 3,7-bis(dimethylamino)phenothiazin-5-ium as the counterion. A commonly used dye that also exhibits antioxidant, antimalarial, antidepressant and cardioprotective properties. | methylene blue |
| metronidazole | A member of the class of imidazoles substituted at C-1, -2 and -5 with 2-hydroxyethyl, nitro and methyl groups respectively. It has activity against anaerobic bacteria and protozoa, and has a radiosensitising effect on hypoxic tumour cells. It may be given by mouth in tablets, or as the benzoate in an oral suspension. The hydrochloride salt can be used in intravenous infusions. Metronidazole is a prodrug and is selective for anaerobic bacteria due to their ability to intracellularly reduce the nitro group of metronidazole to give nitroso-containing intermediates. These can covalently bind to DNA, disrupting its helical structure, inducing DNA strand breaks and inhibiting bacterial nucleic acid synthesis, ultimately resulting in bacterial cell death. | metronidazole |
| mitomycin a | A member of the family of mitomycins that exhibits antibiotic and antitumour properties as well as a high level of toxicity. | mitomycin A |
| ml 236a | A carbobicyclic compound that is ML-236C substituted by a hydroxy group at position 8S. It is a fungal metabolite isolated from Penicillium citrinum and exhibits anticholesteremic activity. | compactin diol lactone |
| monacolin j | A polyketide that is monacolin L bearing an additional hydroxy substituent at position 8. | monacolin J |
| muraymycin d2 | | muraymycin D2 zwitterion |
| mycophenolic acid | A member of the class of 2-benzofurans that is 2-benzofuran-1(3H)-one which is substituted at positions 4, 5, 6, and 7 by methyl, methoxy, (2E)-5-carboxy-3-methylpent-2-en-1-yl, and hydroxy groups, respectively. It is an antibiotic produced by Penicillium brevi-compactum, P. stoloniferum, P. echinulatum and related species. An immunosuppressant, it is widely used (partiularly as its sodium salt and as the 2-(morpholin-4-yl)ethyl ester prodrug, mycophenolate mofetil) to prevent tissue rejection following organ transplants and for the treatment of certain autoimmune diseases. | mycophenolic acid |
| n-cinnamoyltyramine | A member of the class of cinnamamides that is tyramine substituted by a (1E)-3-oxo-1-phenylprop-1-en-3-yl group at the nitrogen atom. It is found in rice and exhibits an allelopathic effect to suppress the growth of weeds. | N-trans-cinnamoyltyramine |
| nalidixic acid | A monocarboxylic acid comprising 1,8-naphthyridin-4-one substituted by carboxylic acid, ethyl and methyl groups at positions 3, 1, and 7, respectively. An orally administered antibacterial, it is used in the treatment of lower urinary-tract infections due to Gram-negative bacteria, including the majority of E. coli, Enterobacter, Klebsiella, and Proteus species. | nalidixic acid |
| nidulalin a | A member of the class xanthones which consists of a dihydroxanthone skeleton substituted by hydroxy groups at positions 4 and 8, a methyl group at position 6 and a methoxycarbonyl group at position 4a (the 4R,4aS stereoisomer). It is isolated from Emericella nidulans var lata and Penicillium and exhibits potent antitumour activity against both human and murine tumour cell lines. | nidulalin A |
| nigericin | A polyether antibiotic which affects ion transport and ATPase activity in mitochondria. It is produced by Streptomyces hygroscopicus. | nigericin |
| nitroxoline | A monohydroxyquinoline in which the hydroxy group is positioned at C-8 with a nitro group trans to it at C-5. | nitroxoline |
| novobiocin | A coumarin-derived antibiotic obtained from Streptomyces niveus. | novobiocin |
| nxl 104 | An organic sodium salt that is the monosodium salt of avibactam. Used in combination with ceftazidime pentahydrate for the treatment of complicated urinary tract infections including pyelonephritis. | avibactam sodium |
| olivomycin a | | olivomycin A |
| oritavancin | A semisynthetic glycopeptide used (as its bisphosphate salt) for the treatment of acute bacterial skin and skin structure infections caused or suspected to be caused by susceptible isolates of designated Gram-positive microorganisms including MRSA. | oritavancin |
| oxolinic acid | A quinolinemonocarboxylic acid having the carboxy group at position 7 as well as oxo and ethyl groups at positions 4 and 1 respectively and a dioxolo ring fused at the 5- and 6-positions. A synthetic antibiotic, it is used in veterinary medicine for the treatment of bacterial infections in cattle, pigs and poultry. | oxolinic acid |
| oxyphenbutazone | A metabolite of phenylbutazone obtained by hydroxylation at position 4 of one of the phenyl rings. Commonly used (as its hydrate) to treat pain, swelling and stiffness associated with arthritis and gout, it was withdrawn from the market 1984 following association with blood dyscrasis and Stevens-Johnson syndrome. | oxyphenbutazone |
| pannarin | A member of the class of depsidones that is 11H-dibenzo[b,e][1,4]dioxepine substituted by methyl groups at positions 1,6 and 9, chloro group at position 2, hydroxy group at position 3, formyl group at position 4, methoxy group at position 8 and an oxo group at position 11. It is a lichen metabolite isolated from several Psoroma species. | pannarin |
| patulin | A furopyran and lactone that is (2H-pyran-3(6H)-ylidene)acetic acid which is substituted by hydroxy groups at positions 2 and 4 and in which the hydroxy group at position 4 has condensed with the carboxy group to give the corresponding bicyclic lactone. A mycotoxin produced by several species of Aspergillus and Penicillium, it has antibiotic properties but has been shown to be carcinogenic and mutagenic. | patulin |
| pentadecanal | A long-chain fatty aldehyde that is pentadecane carrying an oxo substituent at position 1. It is a component of essential oils from plants like Solanum erianthum and Cassia siamea. | pentadecanal |
| phleomycin d1 | A glycopeptide originally isolated from the bacterium Streptomyces verticillus which contains a (4'R)-4',5'-dihydro-2,4'-bi-1,3-thiazole-2',4-diyl moiety with a a 4-guanidylbutylaminocarbonyl group attached to the 4-position of the terminal thiazole ring. Like all phleomycins, phleomycin D1 can form complexes with redox-active metals such as Co, Cu, and Fe. | phleomycin D1 |
| physalin b | A physalin with antimalarial, antitumour and antimicrobial activities isolated from Physalis angulata. | physalin B |
| piericidin a | A member of the class of monohydroxypyridines that acts as an irreversible mitochondrial Complex I inhibitor that strongly associates with ubiquinone binding sites in both mitochondrial and bacterial forms of NADH:ubiquinone oxidoreductase | piericidin A |
| platencin | A monocarboxylic acid amide obtained by the formal condensation of the amino group of 3-amino-2,4-dihydroxybenzoic acid with the carboxy group of the polycyclic cage component. It is an antibiotic isolated from Streptomyces platensis and exhibits inhibitory activity against fatty acid synthase. | platencin |
| platensimycin | A monocarboxylic acid amide obtained by the formal condensation of the amino group of 3-amino-2,4-dihydroxybenzoic acid with the carboxy group of the oxatetracyclic cage component. It is an antibiotic isolated from Streptomyces platensis and exhibits inhibitory activity against fatty acid synthase. | platensimycin |
| ppi-0903 | A cephalosporin having [4-(1-methylpyridinium-4-yl)-1,3-thiazol-2-yl]sulfanyl and {(2Z)-2-(ethoxyimino)-2-[5-(phosphonoamino)-1,2,4-thiadiazol-3-yl]acetyl}amino side groups located at positions 3 and 7 respectively. The N-phospho prodrug of ceftaroline, a broad-spectrum antibiotic active against methicillin-resistant Staphylococcus aureus (MRSA). It is used for the treatment of adults with acute bacterial skin and skin structure infections. | ceftaroline fosamil |
| primin | A 1,4-benzoquinone having a methoxy substituent at the 2-position and a pentyl substituent at the 6-position. | primin |
| propamidine | A polyether that is the bis(4-guanidinophenyl) ether of propane-1,3-diol. Used (as its isethionate salt) for the treatment of minor eye or eyelid infections, such as conjunctivitis and blepharitis. | propamidine |
| propamidine isethionate | A guanidinium salt obtained by combining propamidine with two molar equivalents of isethionic acid. Used for the treatment of minor eye or eyelid infections, such as conjunctivitis and blepharitis. | propamidine isethionate |
| propylparaben | The benzoate ester that is the propyl ester of 4-hydroxybenzoic acid. Preservative typically found in many water-based cosmetics, such as creams, lotions, shampoos and bath products. Also used as a food additive. | propylparaben |
| puromycin | An aminonucleoside antibiotic, derived from the Streptomyces alboniger bacterium, that causes premature chain termination during translation taking place in the ribosome. | puromycin |
| pyrazofurin | A C-glycosyl compound that is 4-hydroxy-1H-pyrazole-5-carboxamide in which the hydrogen at position 3 has been replaced by a beta-D-ribofuranosyl group. | pirazofurin |
| quercetin 3-o-methyl ether | A tetrahydroxyflavone having the 4-hydroxy groups located at the 3'- 4'- 5- and 7-positions as well as a methoxy group at the 2-position. | 3',4',5,7-tetrahydroxy-3-methoxyflavone |
| respirantin | A cyclodepsipeptide isolated from Streptomyces and Kitasatospora and has been shown to exhibit antimicrobial and antineoplastic activity. | respirantin |
| reumycin | A pyrimidotriazine that is 6-methyl-5,6,7,8-tetrahydropyrimido[5,4-e][1,2,4]triazine with oxo groups at positions 5 and 6. | reumycin |
| ribostamycin | An amino cyclitol glycoside that is 4,6-diaminocyclohexane-1,2,3-triol having a 2,6-diamino-2,6-dideoxy-alpha-D-glucosyl residue attached at position 1 and a beta-D-ribosyl residue attached at position 2. It is an antibiotic produced by Streptomyces ribosidificus (formerly S. thermoflavus). | ribostamycin |
| rifamycin sv | A member of the class of rifamycins that exhibits antibiotic and antitubercular properties. | rifamycin SV |
| rifaximin | A semisynthetic member of the class of rifamycins and non-systemic gastrointestinal site-specific broad spectrum antibiotic. Used in the treatment of traveller's diarrhoea, hepatic encephalopathy and irritable bowel syndrome. | rifaximin |
| ristocetin | A heterodetic cyclic peptide that is produced by species of Amycolatopsis and Nocardia. | ristocetin |
| roseoflavin | A benzopteridine that is riboflavin in which the methyl group at position 8 is substituted by a dimethylamino group. | roseoflavin |
| sclareol | A labdane diterpenoid that is labd-14-ene substituted by hydroxy groups at positions 8 and 13. It has been isolated from Salvia sclarea. | sclareol |
| sf 2370 | A organic heterooctacyclic compound that is a potent inhibitor of protein kinase C and is isolated from Nocardiopsis sp K-252a | K-252a |
| silver sulfadiazine | | silver(1+) sulfadiazinate |
| sinefungin | An adenosine that is the the delta-(5'-adenosyl) derivative of ornithine. | sinefungin |
| spectinomycin | A pyranobenzodioxin and antibiotic that is active against gram-negative bacteria and used (as its dihydrochloride pentahydrate) to treat gonorrhea. It is produced by the bacterium Streptomyces spectabilis. | spectinomycin |
| spectinomycin dihydrochloride | A hydrochloride obtained by combining spectinomycin with two molar equivalents of hydrochloric acid. An antibiotic that is active against gram-negative bacteria and used (as its pentahydrate) to treat gonorrhea. | spectinomycin dihydrochloride |
| streptogramin b | A cyclodepsipeptide that is (together with pristinamycin IIA) a component of pristinamycin, an oral streptogramin antibiotic produced by Streptomyces pristinaespiralis. Pristinamycin exhibits bactericidal activity against Gram positive organisms including methicillin-resistant Staphylococcus aureus. | pristinamycin IA |
| streptolydigin | A monocarboxylic acid amide that is a broad-spectrum antibiotic produced by Streptomyces lydicus. | streptolydigin |
| streptomycin | A amino cyclitol glycoside that consists of streptidine having a disaccharyl moiety attached at the 4-position. The parent of the streptomycin class | streptomycin |
| streptonigrin | Complex cytotoxic antibiotic obtained from Streptomyces flocculus or S. rufochronmogenus. It is used in advanced carcinoma and causes leukopenia. | streptonigrin |
| streptothricin f | A primary aliphatic ammonium ion which is obtained from streptothricin F by protonation of the guanidino and amino groups. | streptothricin F(3+) |
| streptozocin | An N-nitrosourea that is an antibiotic produced by Streptomyces achromogenes. It is used as an antineoplastic agent and to induce diabetes in experimental animals. | streptozocin |
| sulfacetamide | A sulfonamide that is sulfanilamide acylated on the sulfonamide nitrogen. | sulfacetamide |
| sulfacetamide sodium | An organic sodium salt that is the monohydrate form of sulfacetamide sodium. | sulfacetamide sodium |
| sulfadiazine | A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position. | sulfadiazine |
| sulfadimethoxine | A sulfonamide consisting of pyrimidine having methoxy substituents at the 2- and 6-positions and a 4-aminobenzenesulfonamido group at the 4-position. | sulfadimethoxine |
| sulfamethazine | A sulfonamide consisting of pyrimidine with methyl substituents at the 4- and 6-positions and a 4-aminobenzenesulfonamido group at the 2-position. | sulfamethazine |
| sulfamethizole | A sulfonamide consisting of a 1,3,4-thiadiazole nucleus with a methyl substituent at C-5 and a 4-aminobenzenesulfonamido group at C-2. | sulfamethizole |
| sulfamethoxazole | An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position. | sulfamethoxazole |
| sulfamoxole | A sulfonamide antibiotic in which 4-aminobenzenesulfonic acid and 4,5-dimethyl-1,3-oxazol-2-amine have combined to form the sulfonamide bond. | sulfamoxole |
| tazobactam | A member of the class of penicillanic acids that is sulbactam in which one of the exocyclic methyl hydrogens is replaced by a 1,2,3-triazol-1-yl group; used (in the form of its sodium salt) in combination with ceftolozane sulfate for treatment of complicated intra-abdominal infections and complicated urinary tract infections. | tazobactam |
| tazobactam sodium | An organic sodium salt having tazobactam(1-) as the counterion; used in combination with ceftolozane sulfate for treatment of complicated intra-abdominal infections and complicated urinary tract infections. | tazobactam sodium |
| tedizolid | A member of the class of pyridines that is pyridine which is substituted by a 2-methyl-2H-tetrazol-5-yl group at position 2 and by a 2-fluoro-4-[(5R)-5-(hydroxymethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl group at position 5. It is used as its phosphate pro-drug used for the treatment of acute bacterial skin and skin structure infections caused by certain susceptible bacteria, including Staphylococcus aureus (including methicillin-resistant strains (MRSA) and methicillin-susceptible strains), various Streptococcus species, and Enterococcus faecalis. | tedizolid |
| tedizolid phosphate | A phosphate monoester resulting from the formal condensation of equimolar amounts of phosphoric acid with the hydroxy group of tedizolid . It is a prodrug of tedizolid, used for the treatment of acute bacterial skin infections caused by certain susceptible bacteria, including Staphylococcus aureus (including methicillin-resistant strains (MRSA) and methicillin-susceptible strains), various Streptococcus species, and Enterococcus faecalis. | tedizolid phosphate |
| telavancin | A glycopeptide that is vancomycin substituted at position N-3'' by a 2-(decylamino)ethyl group and at position C-29 by a (phosphonomethyl)aminomethyl group. Used as its hydrochloride salt for treatment of adults with complicated skin and skin structure infections caused by bacteria. | telavancin |
| thermozymocidin | An amino acid-based antibiotic derived from certain thermophilic fungi; acts as a potent inhibitor of serine palmitoyltransferase, the first step in sphingosine biosynthesis. Myriocin also possesses immunosuppressant activity. | myriocin |
| thiamphenicol | | thiamphenicol |
| thiazomycin | A heterodetic cyclic peptide isolated from Amycolatopsis fastidiosa. | thiazomycin |
| tmc-95a | A 17-membered macrocyclic lactam that incorporates a phenol and a substituted indole moiety. It includes a R-hydroxy group at position 11 and a (3-methyl-2-oxopentanoyl)amino group at position at position 18 with a S-methyl group. It acts as a proteasome inhibitor and is obtained from Apiospora montagnei Sacc. TC 1093, isolated from a soil sample. | TMC-95A |
| tmc-95b | A 17-membered macrocyclic lactam that incorporates a phenol and a substituted indole moiety. A stereoisomer of TMC-95A, it has a [(3R)-3-methyl-2-oxopentanoyl]amino group at position 18. It acts as a proteasome inhibitor and is isolated from Apiospora montagnei Sacc. TC 1093, isolated from a soil sample. | TMC-95B |
| tobramycin | A amino cyclitol glycoside that is kanamycin B lacking the 3-hydroxy substituent from the 2,6-diaminoglucose ring. | tobramycin |
| topopyrone c | A naphthochromene that is 4H-naphtho[2,3-h]chromene-4,7,12-trione substituted by hydroxy groups at positions 5, 9 and 11 and a methyl group at position 2. It is isolated from fungal strains Phoma and Penicillium and acts as an inhibitor of the enzyme topoisomerase I. | topopyrone C |
| tosufloxacin, 4-toluene sulfonate | A racemate comprising equimolar amounts of (R)- and (S)-tosufloxacin tosylate. | tosufloxacin tosylate |
| triclocarban | A member of the class of phenylureas that is urea substituted by a 4-chlorophenyl group and a 3,4-dichlorophenyl group at positions 1 and 3 respectively. | triclocarban |
| valinomycin | A twelve-membered cyclodepsipeptide composed of three repeating D-alpha-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl units joined in sequence. An antibiotic found in several Streptomyces strains. | valinomycin |
| vancomycin | A complex glycopeptide from Streptomyces orientalis. It inhibits a specific step in the synthesis of the peptidoglycan layer in the Gram-positive bacteria Staphylococcus aureus and Clostridium difficile. | vancomycin |
| vexibinol | A tetrahydroxyflavanone having a structure of naringenin bearing an additional hydroxyl substituent at position 2' as well as a (2R)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl (lavandulyl) substituent at position 8'. | sophoraflavanone G |
| vinylamycin | A 15-membered cyclodepsipeptide isolated from Streptomyces sp.M1982-63F1. It exhibits moderate activity against Gram-positive bacteria. | vinylamycin |
| zorbamycin | A glycopeptide antibiotic found in Streptomyces flavoviridis. | zorbamycin |
| Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
|---|
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | Homo sapiens (human) | Potency | 24.8794 | 1 | 20 |
| 15-lipoxygenase, partial | Homo sapiens (human) | Potency | 17.2904 | 1 | 6 |
| 67.9K protein | Vaccinia virus | Potency | 9.2672 | 2 | 26 |
| acetylcholinesterase | Homo sapiens (human) | Potency | 22.8743 | 4 | 19 |
| activating transcription factor 6 | Homo sapiens (human) | Potency | 11.3042 | 2 | 10 |
| Adenosine receptor A1 | Rattus norvegicus (Norway rat) | Potency | 8.9125 | 1 | 1 |
| aldehyde dehydrogenase 1 family, member A1 | Homo sapiens (human) | Potency | 26.6998 | 1 | 31 |
| Alpha-synuclein | Homo sapiens (human) | Potency | 12.4543 | 1 | 9 |
| apical membrane antigen 1, AMA1 | Plasmodium falciparum 3D7 | Potency | 23.8754 | 1 | 8 |
| AR protein | Homo sapiens (human) | Potency | 22.8026 | 12 | 120 |
| aryl hydrocarbon receptor | Homo sapiens (human) | Potency | 20.3426 | 3 | 28 |
| arylsulfatase A | Homo sapiens (human) | Potency | 21.3313 | 1 | 1 |
| ATAD5 protein, partial | Homo sapiens (human) | Potency | 10.0714 | 9 | 34 |
| Ataxin-2 | Homo sapiens (human) | Potency | 19.2685 | 1 | 7 |
| ATP-dependent phosphofructokinase | Trypanosoma brucei brucei TREU927 | Potency | 29.3367 | 3 | 5 |
| ATPase family AAA domain-containing protein 5 | Homo sapiens (human) | Potency | 19.2685 | 1 | 7 |
| beta-2 adrenergic receptor | Homo sapiens (human) | Potency | 20.5013 | 3 | 4 |
| Bloom syndrome protein isoform 1 | Homo sapiens (human) | Potency | 11.9258 | 2 | 6 |
| BRCA1 | Homo sapiens (human) | Potency | 22.3872 | 1 | 1 |
| bromodomain adjacent to zinc finger domain 2B | Homo sapiens (human) | Potency | 39.7463 | 1 | 7 |
| caspase 7, apoptosis-related cysteine protease | Homo sapiens (human) | Potency | 39.7302 | 1 | 2 |
| caspase-1 isoform alpha precursor | Homo sapiens (human) | Potency | 23.7358 | 1 | 2 |
| caspase-3 | Cricetulus griseus (Chinese hamster) | Potency | 28.8647 | 1 | 3 |
| caspase-3 | Homo sapiens (human) | Potency | 39.7302 | 1 | 2 |
| Caspase-7 | Cricetulus griseus (Chinese hamster) | Potency | 28.8647 | 1 | 3 |
| Caspase-7 | Homo sapiens (human) | Potency | 17.9008 | 1 | 2 |
| Cellular tumor antigen p53 | Homo sapiens (human) | Potency | 18.8839 | 3 | 31 |
| cellular tumor antigen p53 isoform a | Homo sapiens (human) | Potency | 17.6879 | 2 | 13 |
| Chain A, 2-oxoglutarate Oxygenase | Homo sapiens (human) | Potency | 22.2532 | 1 | 27 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | Homo sapiens (human) | Potency | 21.2718 | 2 | 5 |
| Chain A, Beta-lactamase | Escherichia coli K-12 | Potency | 26.5516 | 2 | 6 |
| Chain A, Cruzipain | Trypanosoma cruzi | Potency | 25.4770 | 1 | 8 |
| Chain A, Ferritin light chain | Equus caballus (horse) | Potency | 30.1411 | 2 | 6 |
| Chain A, HADH2 protein | Homo sapiens (human) | Potency | 22.5233 | 2 | 19 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | Homo sapiens (human) | Potency | 48.7818 | 1 | 14 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | Homo sapiens (human) | Potency | 23.6090 | 3 | 21 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | Giardia intestinalis | Potency | 17.5859 | 1 | 10 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | Homo sapiens (human) | Potency | 26.1183 | 2 | 15 |
| Chain B, HADH2 protein | Homo sapiens (human) | Potency | 22.5233 | 2 | 19 |
| chaperonin-containing TCP-1 beta subunit homolog | Homo sapiens (human) | Potency | 22.3872 | 1 | 1 |
| chromobox protein homolog 1 | Homo sapiens (human) | Potency | 74.2778 | 2 | 14 |
| ClpP | Bacillus subtilis | Potency | 10.0000 | 1 | 1 |
| core-binding factor subunit beta isoform 2 | Homo sapiens (human) | Potency | 24.8124 | 3 | 3 |
| cytochrome P450 2C19 precursor | Homo sapiens (human) | Potency | 23.4006 | 1 | 4 |
| cytochrome P450 2C9 precursor | Homo sapiens (human) | Potency | 14.2003 | 1 | 5 |
| cytochrome P450 2C9, partial | Homo sapiens (human) | Potency | 20.0576 | 1 | 13 |
| cytochrome P450 2D6 | Homo sapiens (human) | Potency | 25.8344 | 1 | 10 |
| cytochrome P450 2D6 isoform 1 | Homo sapiens (human) | Potency | 19.0387 | 1 | 5 |
| cytochrome P450 3A4 isoform 1 | Homo sapiens (human) | Potency | 31.2561 | 2 | 22 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | Homo sapiens (human) | Potency | 20.7432 | 2 | 14 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | Homo sapiens (human) | Potency | 19.9246 | 1 | 19 |
| D(2) dopamine receptor isoform long | Homo sapiens (human) | Potency | 22.2803 | 1 | 2 |
| Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) | Potency | 4.1856 | 1 | 4 |
| DNA dC->dU-editing enzyme APOBEC-3F isoform a | Homo sapiens (human) | Potency | 17.8338 | 3 | 4 |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | Homo sapiens (human) | Potency | 8.7174 | 2 | 4 |
| DNA polymerase beta | Homo sapiens (human) | Potency | 13.1952 | 1 | 3 |
| DNA polymerase eta isoform 1 | Homo sapiens (human) | Potency | 23.3422 | 2 | 8 |
| DNA polymerase iota isoform a (long) | Homo sapiens (human) | Potency | 50.9851 | 2 | 20 |
| DNA polymerase kappa isoform 1 | Homo sapiens (human) | Potency | 28.9018 | 1 | 14 |
| endonuclease IV | Escherichia coli | Potency | 6.7476 | 2 | 5 |
| estrogen nuclear receptor alpha | Homo sapiens (human) | Potency | 21.9445 | 12 | 155 |
| estrogen receptor 2 (ER beta) | Homo sapiens (human) | Potency | 24.8167 | 3 | 23 |
| estrogen-related nuclear receptor alpha | Homo sapiens (human) | Potency | 21.6704 | 9 | 102 |
| euchromatic histone-lysine N-methyltransferase 2 | Homo sapiens (human) | Potency | 22.5771 | 1 | 20 |
| EWS/FLI fusion protein | Homo sapiens (human) | Potency | 10.0770 | 4 | 21 |
| eyes absent homolog 2 isoform a | Homo sapiens (human) | Potency | 100.0000 | 1 | 2 |
| farnesoid X nuclear receptor | Homo sapiens (human) | Potency | 25.6048 | 5 | 26 |
| flap endonuclease 1 | Homo sapiens (human) | Potency | 24.1207 | 1 | 13 |
| Fumarate hydratase | Homo sapiens (human) | Potency | 11.9428 | 1 | 7 |
| G | Vesicular stomatitis virus | Potency | 20.0576 | 1 | 13 |
| GABA theta subunit | Rattus norvegicus (Norway rat) | Potency | 31.6278 | 1 | 12 |
| galactokinase | Homo sapiens (human) | Potency | 5.1224 | 2 | 2 |
| GALC protein | Homo sapiens (human) | Potency | 0.3162 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | Potency | 31.6278 | 1 | 12 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | Potency | 31.6278 | 1 | 12 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | Potency | 31.6278 | 1 | 12 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | Potency | 31.6278 | 1 | 12 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Rattus norvegicus (Norway rat) | Potency | 31.6278 | 1 | 12 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Rattus norvegicus (Norway rat) | Potency | 31.6278 | 1 | 12 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Rattus norvegicus (Norway rat) | Potency | 31.6278 | 1 | 12 |
| Gamma-aminobutyric acid receptor subunit beta-2 | Rattus norvegicus (Norway rat) | Potency | 31.6278 | 1 | 12 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Rattus norvegicus (Norway rat) | Potency | 31.6278 | 1 | 12 |
| Gamma-aminobutyric acid receptor subunit delta | Rattus norvegicus (Norway rat) | Potency | 31.6278 | 1 | 12 |
| Gamma-aminobutyric acid receptor subunit epsilon | Rattus norvegicus (Norway rat) | Potency | 31.6278 | 1 | 12 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Rattus norvegicus (Norway rat) | Potency | 31.6278 | 1 | 12 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Rattus norvegicus (Norway rat) | Potency | 31.6278 | 1 | 12 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Rattus norvegicus (Norway rat) | Potency | 31.6278 | 1 | 12 |
| Gamma-aminobutyric acid receptor subunit pi | Rattus norvegicus (Norway rat) | Potency | 31.6278 | 1 | 12 |
| geminin | Homo sapiens (human) | Potency | 10.7900 | 2 | 40 |
| GLI family zinc finger 3 | Homo sapiens (human) | Potency | 16.0356 | 3 | 42 |
| glp-1 receptor, partial | Homo sapiens (human) | Potency | 12.2001 | 1 | 11 |
| GLS protein | Homo sapiens (human) | Potency | 19.4965 | 1 | 9 |
| glucocerebrosidase | Homo sapiens (human) | Potency | 39.8107 | 1 | 1 |
| glucocorticoid receptor [Homo sapiens] | Homo sapiens (human) | Potency | 15.2216 | 5 | 35 |
| Glutamate receptor 1 | Rattus norvegicus (Norway rat) | Potency | 10.0000 | 1 | 1 |
| Glutamate receptor 2 | Rattus norvegicus (Norway rat) | Potency | 24.9868 | 2 | 14 |
| Glutamate receptor 3 | Rattus norvegicus (Norway rat) | Potency | 10.0000 | 1 | 1 |
| Glutamate receptor 4 | Rattus norvegicus (Norway rat) | Potency | 10.0000 | 1 | 1 |
| Glycoprotein hormones alpha chain | Homo sapiens (human) | Potency | 13.0642 | 1 | 4 |
| GTP-binding nuclear protein Ran isoform 1 | Homo sapiens (human) | Potency | 9.0977 | 1 | 4 |
| Guanine nucleotide-binding protein G | Homo sapiens (human) | Potency | 21.5636 | 1 | 4 |
| heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | Homo sapiens (human) | Potency | 17.2378 | 1 | 3 |
| heat shock protein beta-1 | Homo sapiens (human) | Potency | 26.8148 | 2 | 14 |
| hepatitis C virus polyprotein | | Potency | 7.0456 | 1 | 1 |
| Histamine H2 receptor | Cavia porcellus (domestic guinea pig) | Potency | 17.8682 | 2 | 19 |
| histone acetyltransferase KAT2A isoform 1 | Homo sapiens (human) | Potency | 22.0838 | 1 | 6 |
| histone deacetylase 9 isoform 3 | Homo sapiens (human) | Potency | 22.0981 | 2 | 9 |
| Histone H2A.x | Cricetulus griseus (Chinese hamster) | Potency | 50.5699 | 2 | 15 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | Homo sapiens (human) | Potency | 11.7504 | 1 | 2 |
| HLA class I histocompatibility antigen, B alpha chain | Homo sapiens (human) | Potency | 20.0576 | 1 | 13 |
| huntingtin isoform 2 | Homo sapiens (human) | Potency | 8.5578 | 3 | 10 |
| hypothetical protein, conserved | Trypanosoma brucei | Potency | 26.6449 | 3 | 5 |
| hypoxia-inducible factor 1 alpha subunit | Homo sapiens (human) | Potency | 31.8636 | 2 | 13 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | Homo sapiens (human) | Potency | 3.8119 | 3 | 7 |
| IDH1 | Homo sapiens (human) | Potency | 8.9047 | 1 | 12 |
| importin subunit beta-1 isoform 1 | Homo sapiens (human) | Potency | 60.6419 | 2 | 10 |
| Inositol hexakisphosphate kinase 1 | Homo sapiens (human) | Potency | 20.0576 | 1 | 26 |
| Inositol monophosphatase 1 | Rattus norvegicus (Norway rat) | Potency | 10.6539 | 2 | 7 |
| Integrin alpha-IIb | Homo sapiens (human) | Potency | 18.7556 | 1 | 5 |
| Integrin beta-3 | Homo sapiens (human) | Potency | 18.7556 | 1 | 5 |
| Interferon beta | Homo sapiens (human) | Potency | 20.8258 | 3 | 30 |
| interleukin 8 | Homo sapiens (human) | Potency | 69.5421 | 1 | 6 |
| isocitrate dehydrogenase 1, partial | Homo sapiens (human) | Potency | 52.1194 | 1 | 1 |
| lamin isoform A-delta10 | Homo sapiens (human) | Potency | 3.0397 | 2 | 19 |
| lethal factor (plasmid) | Bacillus anthracis str. A2012 | Potency | 13.1294 | 1 | 8 |
| lethal(3)malignant brain tumor-like protein 1 isoform I | Homo sapiens (human) | Potency | 19.9526 | 1 | 1 |
| Luciferase | Photinus pyralis (common eastern firefly) | Potency | 26.0113 | 3 | 12 |
| luciferase | Photuris pensylvanica (Pennsylania firefly) | Potency | 10.0000 | 1 | 1 |
| luteinizing hormone receptor | Homo sapiens (human) | Potency | 84.9214 | 1 | 1 |
| lysosomal alpha-glucosidase preproprotein | Homo sapiens (human) | Potency | 35.4813 | 1 | 1 |
| M-phase phosphoprotein 8 | Homo sapiens (human) | Potency | 44.6684 | 1 | 1 |
| Microtubule-associated protein tau | Homo sapiens (human) | Potency | 18.9303 | 2 | 37 |
| mitogen-activated protein kinase 1 | Homo sapiens (human) | Potency | 18.6854 | 2 | 12 |
| muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | Potency | 0.0178 | 1 | 1 |
| muscleblind-like protein 1 isoform 1 | Homo sapiens (human) | Potency | 27.9856 | 1 | 9 |
| neuropeptide S receptor isoform A | Homo sapiens (human) | Potency | 4.8868 | 3 | 4 |
| nonstructural protein 1 | Influenza A virus (A/WSN/1933(H1N1)) | Potency | 2.0624 | 1 | 7 |
| NPC intracellular cholesterol transporter 1 precursor | Homo sapiens (human) | Potency | 3.5049 | 1 | 5 |
| Nrf2 | Homo sapiens (human) | Potency | 17.4940 | 2 | 3 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | Homo sapiens (human) | Potency | 24.8567 | 4 | 50 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | Homo sapiens (human) | Potency | 9.9269 | 2 | 14 |
| nuclear factor NF-kappa-B p105 subunit isoform 1 | Homo sapiens (human) | Potency | 17.7828 | 1 | 1 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | Homo sapiens (human) | Potency | 23.1926 | 1 | 10 |
| Nuclear receptor ROR-gamma | Homo sapiens (human) | Potency | 22.4209 | 1 | 2 |
| nuclear receptor ROR-gamma isoform 1 | Mus musculus (house mouse) | Potency | 10.4220 | 2 | 30 |
| nuclear receptor subfamily 1, group I, member 3 | Homo sapiens (human) | Potency | 22.0298 | 3 | 43 |
| P53 | Homo sapiens (human) | Potency | 28.1838 | 1 | 1 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | Homo sapiens (human) | Potency | 28.6702 | 1 | 6 |
| Parkin | Homo sapiens (human) | Potency | 9.8444 | 1 | 3 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Homo sapiens (human) | Potency | 24.4818 | 2 | 4 |
| peripheral myelin protein 22 | Rattus norvegicus (Norway rat) | Potency | 8.6817 | 2 | 11 |
| peripheral myelin protein 22 isoform 1 | Homo sapiens (human) | Potency | 75.6863 | 1 | 1 |
| peroxisome proliferator activated receptor gamma | Homo sapiens (human) | Potency | 24.4216 | 5 | 30 |
| peroxisome proliferator-activated receptor delta | Homo sapiens (human) | Potency | 24.0591 | 5 | 25 |
| phosphoglycerate kinase | Trypanosoma brucei brucei TREU927 | Potency | 22.9444 | 1 | 5 |
| phosphopantetheinyl transferase | Bacillus subtilis | Potency | 53.1330 | 3 | 8 |
| PINK1 | Homo sapiens (human) | Potency | 9.8444 | 1 | 3 |
| plasminogen precursor | Mus musculus (house mouse) | Potency | 7.0468 | 1 | 8 |
| polyprotein | Zika virus | Potency | 11.9428 | 1 | 7 |
| polyunsaturated fatty acid lipoxygenase ALOX12 | Homo sapiens (human) | Potency | 13.4581 | 1 | 4 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | Homo sapiens (human) | Potency | 31.6228 | 1 | 2 |
| potassium voltage-gated channel subfamily H member 2 isoform d | Homo sapiens (human) | Potency | 15.8553 | 1 | 3 |
| PPM1D protein | Homo sapiens (human) | Potency | 20.0705 | 1 | 10 |
| pregnane X nuclear receptor | Homo sapiens (human) | Potency | 33.4236 | 3 | 24 |
| progesterone receptor | Homo sapiens (human) | Potency | 16.5132 | 2 | 19 |
| pyruvate kinase PKM isoform a | Homo sapiens (human) | Potency | 39.8107 | 2 | 2 |
| Rap guanine nucleotide exchange factor 3 | Homo sapiens (human) | Potency | 60.4953 | 2 | 5 |
| Rap guanine nucleotide exchange factor 4 | Homo sapiens (human) | Potency | 2.5119 | 1 | 2 |
| RAR-related orphan receptor gamma | Mus musculus (house mouse) | Potency | 19.7596 | 2 | 38 |
| ras-related protein Rab-9A | Homo sapiens (human) | Potency | 4.1535 | 1 | 4 |
| regulator of G-protein signaling 4 | Homo sapiens (human) | Potency | 57.7315 | 1 | 2 |
| retinoic acid nuclear receptor alpha variant 1 | Homo sapiens (human) | Potency | 27.8869 | 3 | 54 |
| retinoid X nuclear receptor alpha | Homo sapiens (human) | Potency | 14.7357 | 4 | 43 |
| runt-related transcription factor 1 isoform AML1b | Homo sapiens (human) | Potency | 24.8124 | 3 | 3 |
| serine-protein kinase ATM isoform a | Homo sapiens (human) | Potency | 12.7091 | 5 | 8 |
| serine/threonine-protein kinase PLK1 | Homo sapiens (human) | Potency | 26.0426 | 1 | 4 |
| SMAD family member 2 | Homo sapiens (human) | Potency | 22.2042 | 2 | 11 |
| SMAD family member 3 | Homo sapiens (human) | Potency | 22.2042 | 2 | 11 |
| Smad3 | Homo sapiens (human) | Potency | 9.6555 | 4 | 22 |
| snurportin-1 | Homo sapiens (human) | Potency | 60.6419 | 2 | 10 |
| Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | Potency | 22.0517 | 2 | 15 |
| survival motor neuron protein isoform d | Homo sapiens (human) | Potency | 5.7402 | 2 | 24 |
| T cell receptor, partial | Homo sapiens (human) | Potency | 6.2841 | 1 | 1 |
| TAR DNA-binding protein 43 | Homo sapiens (human) | Potency | 12.9544 | 1 | 12 |
| TDP1 protein | Homo sapiens (human) | Potency | 9.8895 | 2 | 117 |
| thioredoxin glutathione reductase | Schistosoma mansoni | Potency | 35.5052 | 1 | 6 |
| thioredoxin reductase | Rattus norvegicus (Norway rat) | Potency | 43.9040 | 3 | 23 |
| thyroid hormone receptor beta isoform 2 | Rattus norvegicus (Norway rat) | Potency | 19.9114 | 3 | 46 |
| thyroid hormone receptor beta isoform a | Homo sapiens (human) | Potency | 17.0706 | 4 | 8 |
| thyroid stimulating hormone receptor | Homo sapiens (human) | Potency | 18.1755 | 7 | 32 |
| thyrotropin-releasing hormone receptor | Homo sapiens (human) | Potency | 22.9441 | 2 | 2 |
| transcriptional regulator ERG isoform 3 | Homo sapiens (human) | Potency | 6.4117 | 1 | 3 |
| TSHR protein | Homo sapiens (human) | Potency | 15.5035 | 2 | 2 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | Homo sapiens (human) | Potency | 11.9964 | 2 | 5 |
| urokinase plasminogen activator surface receptor precursor | Mus musculus (house mouse) | Potency | 7.0468 | 1 | 8 |
| urokinase-type plasminogen activator precursor | Mus musculus (house mouse) | Potency | 7.0468 | 1 | 8 |
| USP1 protein, partial | Homo sapiens (human) | Potency | 45.4132 | 2 | 14 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | Homo sapiens (human) | Potency | 16.6115 | 2 | 32 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | Homo sapiens (human) | Potency | 25.8005 | 5 | 18 |
| vitamin D3 receptor isoform VDRA | Homo sapiens (human) | Potency | 37.7814 | 5 | 21 |
| Voltage-dependent calcium channel gamma-2 subunit | Mus musculus (house mouse) | Potency | 26.1396 | 1 | 13 |
| Vpr | Human immunodeficiency virus 1 | Potency | 21.7867 | 1 | 3 |
| WRN | Homo sapiens (human) | Potency | 34.7096 | 1 | 3 |
| Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
|---|
| 1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | Homo sapiens (human) | IC50 | 4.5885 | 2 | 2 |
| 1-deoxy-D-xylulose 5-phosphate reductoisomerase | Escherichia coli K-12 | IC50 | 231.6542 | 8 | 8 |
| 1-deoxy-D-xylulose 5-phosphate reductoisomerase | Mycobacterium tuberculosis H37Rv | IC50 | 0.1650 | 6 | 6 |
| 1-deoxy-D-xylulose 5-phosphate reductoisomerase | Mycolicibacterium smegmatis MC2 155 | IC50 | 0.2950 | 2 | 2 |
| 1-deoxy-D-xylulose 5-phosphate reductoisomerase | Mycobacterium tuberculosis H37Rv | Ki | 0.1400 | 1 | 1 |
| 1-deoxy-D-xylulose 5-phosphate reductoisomerase | Synechocystis sp. PCC 6803 substr. Kazusa | Ki | 0.0210 | 1 | 1 |
| 1-deoxy-D-xylulose 5-phosphate reductoisomerase | Escherichia coli | IC50 | 0.4380 | 1 | 1 |
| 1-deoxy-D-xylulose 5-phosphate reductoisomerase, chloroplastic | Arabidopsis thaliana (thale cress) | IC50 | 0.1000 | 1 | 1 |
| 10 kDa chaperonin | Escherichia coli | IC50 | 100.0000 | 2 | 2 |
| 10 kDa heat shock protein, mitochondrial | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| 3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ | Yersinia pseudotuberculosis YPIII | IC50 | 6.9000 | 1 | 2 |
| 3-oxoacyl-[acyl-carrier-protein] synthase 2 | Staphylococcus aureus | IC50 | 4.5800 | 1 | 1 |
| 3-oxoacyl-acyl-carrier protein reductase | Plasmodium falciparum (malaria parasite P. falciparum) | IC50 | 100.0000 | 1 | 1 |
| 30S ribosomal protein S1 | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 30S ribosomal protein S10 | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 30S ribosomal protein S11 | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 30S ribosomal protein S12 | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 30S ribosomal protein S13 | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 30S ribosomal protein S14 | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 30S ribosomal protein S15 | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 30S ribosomal protein S16 | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 30S ribosomal protein S17 | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 30S ribosomal protein S18 | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 30S ribosomal protein S19 | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 30S ribosomal protein S2 | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 30S ribosomal protein S20 | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 30S ribosomal protein S21 | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 30S ribosomal protein S3 | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 30S ribosomal protein S4 | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 30S ribosomal protein S5 | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 30S ribosomal protein S6 | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 30S ribosomal protein S7 | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 30S ribosomal protein S8 | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 30S ribosomal protein S9 | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | IC50 | 17.0333 | 3 | 3 |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | IC50 | 4.7000 | 1 | 1 |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | IC50 | 1.1060 | 1 | 1 |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | Ki | 0.7040 | 1 | 1 |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | Ki | 1.1000 | 1 | 1 |
| 5-hydroxytryptamine receptor 3A | Homo sapiens (human) | IC50 | 141.2540 | 1 | 1 |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | IC50 | 1.3390 | 1 | 1 |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | Ki | 0.6220 | 1 | 1 |
| 50S ribosomal protein L1 | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 50S ribosomal protein L10 | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 50S ribosomal protein L11 | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 50S ribosomal protein L13 | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 50S ribosomal protein L14 | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 50S ribosomal protein L15 | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 50S ribosomal protein L16 | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 50S ribosomal protein L17 | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 50S ribosomal protein L18 | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 50S ribosomal protein L19 | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 50S ribosomal protein L2 | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 50S ribosomal protein L20 | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 50S ribosomal protein L21 | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 50S ribosomal protein L22 | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 50S ribosomal protein L23 | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 50S ribosomal protein L24 | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 50S ribosomal protein L25 | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 50S ribosomal protein L27 | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 50S ribosomal protein L28 | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 50S ribosomal protein L29 | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 50S ribosomal protein L3 | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 50S ribosomal protein L30 | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 50S ribosomal protein L31 | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 50S ribosomal protein L31 type B | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 50S ribosomal protein L32 | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 50S ribosomal protein L33 | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 50S ribosomal protein L34 | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 50S ribosomal protein L35 | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 50S ribosomal protein L36 | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 50S ribosomal protein L36 2 | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 50S ribosomal protein L4 | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 50S ribosomal protein L5 | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 50S ribosomal protein L6 | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 50S ribosomal protein L7/L12 | Escherichia coli K-12 | IC50 | 7.1100 | 2 | 3 |
| 60 kDa chaperonin | Escherichia coli | IC50 | 100.0000 | 2 | 2 |
| 60 kDa heat shock protein, mitochondrial | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| 7,8-dihydro-8-oxoguanine triphosphatase | Homo sapiens (human) | IC50 | 0.4700 | 1 | 1 |
| 72 kDa type IV collagenase | Homo sapiens (human) | IC50 | 9.9000 | 1 | 1 |
| 90-kda heat shock protein beta HSP90 beta, partial | Homo sapiens (human) | IC50 | 50.0000 | 1 | 1 |
| Acetylcholinesterase | Electrophorus electricus (electric eel) | IC50 | 151.7767 | 3 | 3 |
| Acetylcholinesterase | Homo sapiens (human) | IC50 | 55.6007 | 6 | 6 |
| Acetylcholinesterase | Homo sapiens (human) | Ki | 85.6000 | 1 | 1 |
| Acrosin | Sus scrofa (pig) | Ki | 3.5000 | 1 | 1 |
| Acyl carrier protein, mitochondrial | Bos taurus (cattle) | IC50 | 0.0050 | 1 | 1 |
| Adenosine receptor A2a | Homo sapiens (human) | Ki | 22.6000 | 3 | 3 |
| Adenosine receptor A3 | Homo sapiens (human) | Ki | 3.1500 | 2 | 2 |
| Adenylosuccinate synthetase isozyme 2 | Homo sapiens (human) | IC50 | 3.5000 | 1 | 1 |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 0.5000 | 1 | 1 |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 1.0000 | 1 | 1 |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 0.5000 | 1 | 1 |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 1.0000 | 1 | 1 |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 0.5000 | 1 | 1 |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 1.0000 | 1 | 1 |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | Ki | 0.0501 | 1 | 1 |
| Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 0.5629 | 2 | 2 |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | Ki | 3.2000 | 1 | 1 |
| Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 0.5629 | 2 | 2 |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | Ki | 3.7000 | 1 | 1 |
| Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 0.5629 | 2 | 2 |
| Alpha-ketoglutarate-dependent dioxygenase FTO | Homo sapiens (human) | IC50 | 300.0000 | 1 | 1 |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | IC50 | 10.8200 | 4 | 5 |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | Ki | 2.0000 | 1 | 1 |
| Amine oxidase [flavin-containing] B | Homo sapiens (human) | IC50 | 4.6750 | 2 | 2 |
| Aminopeptidase N | Homo sapiens (human) | IC50 | 41.0000 | 1 | 1 |
| Aminopeptidase N | Sus scrofa (pig) | IC50 | 100.0000 | 1 | 1 |
| Amyloid-beta precursor protein | Homo sapiens (human) | IC50 | 186.6833 | 6 | 6 |
| Androgen receptor | Rattus norvegicus (Norway rat) | IC50 | 309.0300 | 1 | 1 |
| Angiotensin-converting enzyme | Rattus norvegicus (Norway rat) | IC50 | 48.0000 | 1 | 4 |
| Angiotensin-converting enzyme | Homo sapiens (human) | Ki | 167.0000 | 1 | 1 |
| Apoptotic peptidase activating factor 1 | Homo sapiens (human) | IC50 | 57.7250 | 2 | 4 |
| Aromatase | Homo sapiens (human) | IC50 | 20.7000 | 1 | 1 |
| Aromatase | Homo sapiens (human) | Ki | 100.0000 | 1 | 1 |
| ATP-binding cassette sub-family C member 3 | Homo sapiens (human) | IC50 | 128.1429 | 1 | 14 |
| ATP-dependent 6-phosphofructokinase | Trypanosoma brucei brucei | IC50 | 57.0000 | 1 | 1 |
| ATP-dependent molecular chaperone HSP82 | Saccharomyces cerevisiae S288C | IC50 | 3.9667 | 2 | 3 |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | IC50 | 3.2000 | 1 | 1 |
| Aurora kinase A | Homo sapiens (human) | IC50 | 21.0000 | 1 | 1 |
| Aurora kinase B | Homo sapiens (human) | IC50 | 9.8000 | 1 | 1 |
| B2 bradykinin receptor | Cavia porcellus (domestic guinea pig) | IC50 | 4.8000 | 1 | 1 |
| Bcl-2-like protein 1 | Homo sapiens (human) | IC50 | 37.4167 | 4 | 6 |
| Bcl-2-like protein 11 | Homo sapiens (human) | IC50 | 13.4375 | 4 | 8 |
| Beta lactamase (plasmid) | Pseudomonas aeruginosa | IC50 | 46.6480 | 1 | 2 |
| Beta-lactamase | Bacillus licheniformis | IC50 | 0.5100 | 1 | 1 |
| Beta-lactamase | Citrobacter freundii | IC50 | 0.9300 | 1 | 1 |
| Beta-lactamase | Enterobacter cloacae | IC50 | 58.7791 | 21 | 22 |
| Beta-lactamase | Escherichia coli K-12 | IC50 | 49.6062 | 8 | 8 |
| Beta-lactamase | Morganella morganii | IC50 | 0.1900 | 1 | 1 |
| Beta-lactamase | Pseudomonas aeruginosa PAO1 | IC50 | 8.7316 | 4 | 5 |
| Beta-lactamase | Staphylococcus aureus | IC50 | 8.7039 | 7 | 7 |
| Beta-lactamase | Bacillus licheniformis | Ki | 490.0000 | 1 | 1 |
| Beta-lactamase | Enterobacter cloacae | Ki | 88.8500 | 1 | 2 |
| Beta-lactamase | Burkholderia cenocepacia | IC50 | 0.5000 | 1 | 1 |
| Beta-lactamase | Citrobacter freundii | IC50 | 0.0960 | 1 | 1 |
| Beta-lactamase | Citrobacter gillenii | IC50 | 0.0400 | 1 | 1 |
| Beta-lactamase | Enterobacter cloacae | IC50 | 15.0771 | 7 | 7 |
| Beta-lactamase | Escherichia coli | IC50 | 42.8130 | 4 | 4 |
| Beta-lactamase | Klebsiella pneumoniae | IC50 | 0.0800 | 1 | 1 |
| Beta-lactamase | Pseudomonas aeruginosa | IC50 | 1.3533 | 3 | 3 |
| Beta-lactamase | Pseudomonas luteola | IC50 | 0.0400 | 1 | 1 |
| Beta-lactamase | Salmonella enterica subsp. enterica serovar Westhampton | IC50 | 0.0022 | 1 | 1 |
| Beta-lactamase | Serratia fonticola | IC50 | 6.9000 | 1 | 1 |
| Beta-lactamase | Shouchella clausii | IC50 | 0.0040 | 1 | 1 |
| Beta-lactamase | Acinetobacter baumannii | Ki | 1.7000 | 1 | 1 |
| Beta-lactamase | Escherichia coli | Ki | 0.0110 | 1 | 1 |
| Beta-lactamase OXA-1 | Escherichia coli | IC50 | 4.8000 | 1 | 1 |
| Beta-lactamase SHV-1 | Escherichia coli | IC50 | 0.2220 | 1 | 1 |
| Beta-lactamase SHV-1 | Klebsiella pneumoniae | IC50 | 0.1100 | 1 | 1 |
| Beta-lactamase SHV-1 | Klebsiella pneumoniae | Ki | 0.2200 | 1 | 1 |
| Beta-lactamase TEM | Escherichia coli | IC50 | 0.0722 | 12 | 12 |
| Beta-lactamase TEM | Escherichia coli | Ki | 0.1900 | 1 | 1 |
| Beta-secretase 1 | Homo sapiens (human) | IC50 | 5.2000 | 1 | 1 |
| Beta-secretase 1 | Homo sapiens (human) | Ki | 1.1000 | 1 | 1 |
| Bifunctional epoxide hydrolase 2 | Homo sapiens (human) | IC50 | 0.0130 | 1 | 1 |
| Bile salt export pump | Homo sapiens (human) | IC50 | 401.2503 | 8 | 39 |
| Bile salt export pump | Rattus norvegicus (Norway rat) | IC50 | 501.5500 | 1 | 2 |
| Bile salt export pump | Homo sapiens (human) | Ki | 31.0000 | 1 | 1 |
| Bile salt export pump | Rattus norvegicus (Norway rat) | Ki | 3.8000 | 1 | 1 |
| BlaVIM-1 | Escherichia coli | Ki | 40.0000 | 1 | 1 |
| Botulinum neurotoxin type A | Clostridium botulinum | IC50 | 20.3000 | 1 | 1 |
| Breakpoint cluster region protein | Homo sapiens (human) | IC50 | 3.0000 | 2 | 2 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | IC50 | 44.4828 | 7 | 7 |
| Bromodomain-containing protein 4 | Homo sapiens (human) | IC50 | 0.9800 | 2 | 2 |
| cAMP-dependent protein kinase | Oryctolagus cuniculus (rabbit) | IC50 | 0.0000 | 1 | 1 |
| cAMP-dependent protein kinase catalytic subunit alpha | Bos taurus (cattle) | IC50 | 0.1450 | 1 | 2 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | Homo sapiens (human) | IC50 | 1.8700 | 1 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Homo sapiens (human) | IC50 | 1.8700 | 1 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4C | Homo sapiens (human) | IC50 | 1.8700 | 1 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Homo sapiens (human) | IC50 | 5.7950 | 4 | 4 |
| Canalicular multispecific organic anion transporter 1 | Homo sapiens (human) | IC50 | 123.9538 | 1 | 13 |
| Cannabinoid receptor 1 | Homo sapiens (human) | Ki | 3.1398 | 4 | 4 |
| Cannabinoid receptor 1 | Rattus norvegicus (Norway rat) | Ki | 10.0000 | 1 | 1 |
| Cannabinoid receptor 2 | Homo sapiens (human) | Ki | 4.0230 | 4 | 4 |
| Carbapenem-hydrolyzing beta-lactamase KPC | Klebsiella pneumoniae | IC50 | 0.3720 | 2 | 2 |
| Carbapenem-hydrolyzing beta-lactamase KPC | Klebsiella pneumoniae | Ki | 74.0000 | 1 | 1 |
| Carbonic anhydrase 1 | Homo sapiens (human) | IC50 | 12.7203 | 1 | 3 |
| Carbonic anhydrase 1 | Homo sapiens (human) | Ki | 7.4300 | 2 | 2 |
| Carbonic anhydrase 12 | Homo sapiens (human) | Ki | 3.8709 | 2 | 2 |
| Carbonic anhydrase 13 | Homo sapiens (human) | Ki | 9.7300 | 1 | 1 |
| Carbonic anhydrase 15 | Mus musculus (house mouse) | Ki | 2.3300 | 1 | 1 |
| Carbonic anhydrase 2 | Homo sapiens (human) | IC50 | 12.7203 | 1 | 3 |
| Carbonic anhydrase 2 | Mycobacterium tuberculosis H37Rv | IC50 | 2.3000 | 1 | 1 |
| Carbonic anhydrase 2 | Homo sapiens (human) | Ki | 52.1500 | 2 | 2 |
| Carbonic anhydrase 4 | Homo sapiens (human) | Ki | 0.5683 | 1 | 1 |
| Carbonic anhydrase 6 | Homo sapiens (human) | IC50 | 12.7203 | 1 | 3 |
| Carbonic anhydrase 7 | Homo sapiens (human) | Ki | 2.1722 | 2 | 2 |
| Carbonic anhydrase 9 | Homo sapiens (human) | Ki | 0.6100 | 1 | 1 |
| carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 | Homo sapiens (human) | IC50 | 2.7860 | 1 | 1 |
| caspase recruitment domain family, member 15 | Homo sapiens (human) | IC50 | 28.1920 | 1 | 2 |
| caspase-3 isoform a preproprotein | Homo sapiens (human) | IC50 | 14.2000 | 1 | 2 |
| caspase-9 isoform alpha precursor | Homo sapiens (human) | IC50 | 14.2000 | 1 | 2 |
| Catechol O-methyltransferase | Rattus norvegicus (Norway rat) | IC50 | 12.3694 | 1 | 2 |
| Cathepsin B | Homo sapiens (human) | Ki | 155.2333 | 6 | 6 |
| Chain A, Ermc' Methyltransferase | Bacillus subtilis | Ki | 18.0000 | 1 | 1 |
| Chain A, Ermc' Rrna Methyltransferase | Bacillus subtilis | Ki | 18.0000 | 1 | 1 |
| Chain A, Inosine-5'-Monophosphate Dehydrogenase 2 | Cricetulus griseus (Chinese hamster) | Ki | 0.0060 | 1 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | Homo sapiens (human) | IC50 | 40,000.0000 | 1 | 26 |
| Chain A, Serine/threonine-protein kinase pknB | Mycobacterium tuberculosis | IC50 | 1.0000 | 1 | 1 |
| Chain B, Cathepsin B | Homo sapiens (human) | Ki | 154.4000 | 1 | 1 |
| Chain C, DNA-directed RNA polymerase beta chain | Thermus thermophilus | Ki | 1.8000 | 1 | 1 |
| Chain D, DNA-directed RNA polymerase subunit beta' chain | Thermus thermophilus | Ki | 1.8000 | 1 | 1 |
| Chain E, Fibrin beta chain | Homo sapiens (human) | IC50 | 46.2655 | 2 | 2 |
| Cholinesterase | Equus caballus (horse) | IC50 | 205.7300 | 2 | 2 |
| Cholinesterase | Homo sapiens (human) | IC50 | 18.0000 | 1 | 1 |
| Chymotrypsinogen A | Bos taurus (cattle) | IC50 | 434.5000 | 2 | 2 |
| Class D beta-lactamase | Brachyspira pilosicoli | IC50 | 0.1600 | 1 | 1 |
| Cruzipain | Trypanosoma cruzi | IC50 | 70.0000 | 2 | 2 |
| Cyclic GMP-AMP synthase | Homo sapiens (human) | IC50 | 0.0040 | 1 | 1 |
| Cyclin-dependent kinase 2 | Homo sapiens (human) | IC50 | 0.1450 | 1 | 2 |
| Cyclin-dependent kinase 4 | Homo sapiens (human) | IC50 | 0.1450 | 1 | 2 |
| Cystathionine gamma-lyase | Homo sapiens (human) | IC50 | 8.2333 | 3 | 3 |
| Cytochrome P450 1A1 | Homo sapiens (human) | IC50 | 0.0770 | 1 | 1 |
| Cytochrome P450 1A1 | Homo sapiens (human) | Ki | 0.1600 | 1 | 1 |
| Cytochrome P450 1A2 | Homo sapiens (human) | IC50 | 16.6847 | 3 | 3 |
| Cytochrome P450 1A2 | Homo sapiens (human) | Ki | 2.6900 | 1 | 1 |
| Cytochrome P450 1B1 | Homo sapiens (human) | IC50 | 0.0140 | 2 | 2 |
| Cytochrome P450 1B1 | Homo sapiens (human) | Ki | 3.6300 | 1 | 1 |
| Cytochrome P450 2A6 | Homo sapiens (human) | Ki | 55.0000 | 1 | 1 |
| Cytochrome P450 2B6 | Homo sapiens (human) | IC50 | 0.1100 | 1 | 1 |
| Cytochrome P450 2B6 | Homo sapiens (human) | Ki | 0.6900 | 1 | 1 |
| Cytochrome P450 2C11 | Rattus norvegicus (Norway rat) | Ki | 20.7000 | 1 | 1 |
| Cytochrome P450 2C19 | Homo sapiens (human) | IC50 | 25.0370 | 2 | 2 |
| Cytochrome P450 2C19 | Homo sapiens (human) | Ki | 0.7900 | 1 | 1 |
| Cytochrome P450 2C9 | Homo sapiens (human) | IC50 | 29.2665 | 3 | 3 |
| Cytochrome P450 2C9 | Homo sapiens (human) | Ki | 5.6000 | 1 | 1 |
| Cytochrome P450 2D6 | Homo sapiens (human) | IC50 | 25.0070 | 2 | 2 |
| Cytochrome P450 2D6 | Homo sapiens (human) | Ki | 2.4200 | 1 | 1 |
| Cytochrome P450 3A4 | Homo sapiens (human) | IC50 | 184.7305 | 5 | 5 |
| Cytochrome P450 3A4 | Homo sapiens (human) | Ki | 5.8000 | 2 | 2 |
| Cytochrome P450 3A43 | Homo sapiens (human) | IC50 | 0.0140 | 1 | 1 |
| Cytochrome P450 3A5 | Homo sapiens (human) | IC50 | 0.0140 | 1 | 1 |
| Cytochrome P450 3A5 | Homo sapiens (human) | Ki | 0.1900 | 1 | 1 |
| Cytochrome P450 3A7 | Homo sapiens (human) | IC50 | 0.0140 | 1 | 1 |
| Cytochrome P450 3A7 | Homo sapiens (human) | Ki | 12.3000 | 1 | 1 |
| D | Rattus norvegicus (Norway rat) | IC50 | 75.0000 | 1 | 1 |
| D-alanyl-D-alanine dipeptidase | Enterococcus faecium | Ki | 62.0000 | 1 | 1 |
| D(1A) dopamine receptor | Homo sapiens (human) | Ki | 2.7000 | 1 | 1 |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | IC50 | 59.0000 | 1 | 1 |
| delta-type opioid receptor | Homo sapiens (human) | IC50 | 32.0000 | 1 | 1 |
| Delta-type opioid receptor | Mus musculus (house mouse) | IC50 | 0.5800 | 1 | 1 |
| Delta-type opioid receptor | Homo sapiens (human) | Ki | 6.4000 | 1 | 1 |
| Diacylglycerol lipase-alpha | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| Dihydrofolate reductase | Homo sapiens (human) | IC50 | 18.0000 | 1 | 1 |
| Dihydrofolate reductase | Pneumocystis carinii | IC50 | 0.1000 | 1 | 1 |
| Dihydrofolate reductase | Bos taurus (cattle) | IC50 | 22.0000 | 1 | 1 |
| Dihydrolipoyl dehydrogenase | Plasmodium falciparum (malaria parasite P. falciparum) | IC50 | 1,000.0000 | 1 | 1 |
| Dihydrolipoyl dehydrogenase, mitochondrial | Sus scrofa (pig) | IC50 | 1,000.0000 | 1 | 1 |
| Dihydroorotate dehydrogenase | Leishmania major | IC50 | 490.8935 | 1 | 2 |
| Dihydropteroate synthase | Escherichia coli K-12 | IC50 | 4.7000 | 1 | 1 |
| Dipeptidyl peptidase 3 | Homo sapiens (human) | IC50 | 23.4000 | 1 | 1 |
| Dipeptidyl peptidase 4 | Homo sapiens (human) | IC50 | 0.0010 | 1 | 1 |
| DNA (cytosine-5)-methyltransferase 1 isoform b | Homo sapiens (human) | IC50 | 7.2800 | 1 | 1 |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | Homo sapiens (human) | IC50 | 28.6750 | 1 | 2 |
| DNA gyrase subunit A | Bacillus subtilis subsp. subtilis str. 168 | IC50 | 77.6500 | 1 | 2 |
| DNA gyrase subunit A | Escherichia coli K-12 | IC50 | 11.3017 | 35 | 41 |
| DNA gyrase subunit A | Mycobacterium tuberculosis H37Rv | IC50 | 259.8511 | 18 | 19 |
| DNA gyrase subunit A | Staphylococcus aureus | IC50 | 66.4582 | 31 | 39 |
| DNA gyrase subunit A | Escherichia coli K-12 | Ki | 0.0447 | 1 | 3 |
| DNA gyrase subunit A | Staphylococcus aureus | Ki | 0.0360 | 2 | 4 |
| DNA gyrase subunit B | Bacillus subtilis subsp. subtilis str. 168 | IC50 | 77.6500 | 1 | 2 |
| DNA gyrase subunit B | Escherichia coli K-12 | IC50 | 8.0642 | 35 | 41 |
| DNA gyrase subunit B | Mycobacterium tuberculosis H37Rv | IC50 | 346.0551 | 14 | 14 |
| DNA gyrase subunit B | Mycolicibacterium smegmatis | IC50 | 25.8523 | 7 | 7 |
| DNA gyrase subunit B | Mycolicibacterium smegmatis MC2 155 | IC50 | 0.0460 | 1 | 1 |
| DNA gyrase subunit B | Staphylococcus aureus | IC50 | 23.5071 | 32 | 38 |
| DNA gyrase subunit B | Streptococcus pneumoniae TIGR4 | IC50 | 0.0370 | 1 | 1 |
| DNA gyrase subunit B | Escherichia coli K-12 | Ki | 0.0353 | 2 | 4 |
| DNA gyrase subunit B | Staphylococcus aureus | Ki | 0.0360 | 2 | 4 |
| DNA polymerase alpha catalytic subunit | Homo sapiens (human) | IC50 | 5.1500 | 6 | 6 |
| DNA polymerase beta | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| DNA polymerase beta | Rattus norvegicus (Norway rat) | IC50 | 100.0000 | 1 | 1 |
| DNA polymerase catalytic subunit | Human alphaherpesvirus 1 strain 17 | IC50 | 0.5000 | 1 | 1 |
| DNA polymerase catalytic subunit | Human alphaherpesvirus 1 strain KOS | IC50 | 0.4380 | 1 | 1 |
| DNA polymerase catalytic subunit | Human herpesvirus 3 strain Dumas | IC50 | 1.6000 | 1 | 2 |
| DNA polymerase catalytic subunit | Human herpesvirus 5 strain AD169 | IC50 | 0.4435 | 2 | 2 |
| DNA polymerase catalytic subunit | Human herpesvirus 6 (strain Uganda-1102) | IC50 | 0.4000 | 1 | 1 |
| DNA polymerase delta catalytic subunit | Homo sapiens (human) | IC50 | 40.0000 | 1 | 1 |
| DNA polymerase lambda | Homo sapiens (human) | IC50 | 200.0000 | 1 | 1 |
| DNA polymerase subunit gamma-1 | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| DNA topoisomerase | Streptococcus pneumoniae | IC50 | 2.0300 | 1 | 1 |
| DNA topoisomerase 1 | Mus musculus (house mouse) | IC50 | 172.0000 | 1 | 1 |
| DNA topoisomerase 2 | Drosophila melanogaster (fruit fly) | IC50 | 2.2000 | 1 | 1 |
| DNA topoisomerase 2-alpha | Homo sapiens (human) | IC50 | 191.4000 | 3 | 4 |
| DNA topoisomerase 4 subunit A | Bacillus subtilis subsp. subtilis str. 168 | IC50 | 545.8500 | 1 | 2 |
| DNA topoisomerase 4 subunit A | Escherichia coli K-12 | IC50 | 51.0000 | 1 | 1 |
| DNA topoisomerase 4 subunit A | Staphylococcus aureus | IC50 | 10.9241 | 15 | 17 |
| DNA topoisomerase 4 subunit A | Escherichia coli K-12 | Ki | 0.0447 | 1 | 3 |
| DNA topoisomerase 4 subunit B | Bacillus subtilis subsp. subtilis str. 168 | IC50 | 545.8500 | 1 | 2 |
| DNA topoisomerase 4 subunit B | Staphylococcus aureus | IC50 | 14.5675 | 12 | 12 |
| DNA topoisomerase 4 subunit B | Escherichia coli K-12 | Ki | 0.0447 | 1 | 3 |
| DNA-directed RNA polymerase subunit beta | Escherichia coli K-12 | IC50 | 50.0100 | 1 | 5 |
| DNA-directed RNA polymerase subunit beta | Shigella sonnei Ss046 | IC50 | 50.0100 | 1 | 5 |
| E3 ubiquitin-protein ligase XIAP | Homo sapiens (human) | IC50 | 4.1000 | 3 | 3 |
| E3 ubiquitin-protein ligase XIAP | Homo sapiens (human) | Ki | 0.4000 | 1 | 1 |
| Endoplasmin | Canis lupus familiaris (dog) | IC50 | 0.0100 | 1 | 1 |
| Endothelin-1 receptor | Rattus norvegicus (Norway rat) | IC50 | 223.3333 | 3 | 3 |
| Enoyl-acyl-carrier protein reductase | Plasmodium falciparum (malaria parasite P. falciparum) | IC50 | 35.2000 | 1 | 1 |
| Epidermal growth factor receptor | Homo sapiens (human) | IC50 | 5.3770 | 1 | 1 |
| Epoxide hydrolase B | Mycobacterium tuberculosis CDC1551 | IC50 | 0.2200 | 2 | 2 |
| exodeoxyribonuclease V subunit RecB | Escherichia coli str. K-12 substr. MG1655 | IC50 | 99.8133 | 2 | 3 |
| exodeoxyribonuclease V subunit RecC | Escherichia coli str. K-12 substr. MG1655 | IC50 | 99.8133 | 2 | 3 |
| exodeoxyribonuclease V subunit RecD | Escherichia coli str. K-12 substr. MG1655 | IC50 | 99.8133 | 2 | 3 |
| Fatty acid synthase | Gallus gallus (chicken) | IC50 | 13.0000 | 1 | 1 |
| Fatty acid synthase | Homo sapiens (human) | IC50 | 11.5500 | 4 | 4 |
| Fatty acid-binding protein, liver | Mus musculus (house mouse) | Ki | 0.1670 | 1 | 1 |
| G-protein coupled receptor 84 | Homo sapiens (human) | Ki | 0.0236 | 1 | 1 |
| G1/S-specific cyclin-D1 | Homo sapiens (human) | IC50 | 0.1450 | 1 | 2 |
| G1/S-specific cyclin-E1 | Homo sapiens (human) | IC50 | 0.1450 | 1 | 2 |
| GABA theta subunit | Rattus norvegicus (Norway rat) | IC50 | 50.2050 | 2 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | IC50 | 50.2050 | 2 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | IC50 | 50.2050 | 2 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | IC50 | 50.2050 | 2 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | IC50 | 50.2050 | 2 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Rattus norvegicus (Norway rat) | IC50 | 50.2050 | 2 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Rattus norvegicus (Norway rat) | IC50 | 50.2050 | 2 | 4 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Rattus norvegicus (Norway rat) | IC50 | 50.2050 | 2 | 4 |
| Gamma-aminobutyric acid receptor subunit beta-2 | Rattus norvegicus (Norway rat) | IC50 | 50.2050 | 2 | 4 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Rattus norvegicus (Norway rat) | IC50 | 50.2050 | 2 | 4 |
| Gamma-aminobutyric acid receptor subunit delta | Rattus norvegicus (Norway rat) | IC50 | 50.2050 | 2 | 4 |
| Gamma-aminobutyric acid receptor subunit epsilon | Rattus norvegicus (Norway rat) | IC50 | 50.2050 | 2 | 4 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Rattus norvegicus (Norway rat) | IC50 | 50.2050 | 2 | 4 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Rattus norvegicus (Norway rat) | IC50 | 50.2050 | 2 | 4 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Rattus norvegicus (Norway rat) | IC50 | 50.2050 | 2 | 4 |
| Gamma-aminobutyric acid receptor subunit pi | Rattus norvegicus (Norway rat) | IC50 | 50.2050 | 2 | 4 |
| Genome polyprotein | | IC50 | 2.2750 | 2 | 2 |
| Genome polyprotein | Human rhinovirus sp. | IC50 | 1,263.0000 | 2 | 2 |
| Genome polyprotein | Zika virus | IC50 | 14.2000 | 1 | 1 |
| Glucose transporter | Leishmania mexicana | IC50 | 0.2250 | 1 | 1 |
| glucose-6-phosphate 1-dehydrogenase isoform b | Homo sapiens (human) | IC50 | 80.0000 | 1 | 1 |
| glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | Plasmodium berghei | IC50 | 63.1250 | 3 | 4 |
| Glutamate receptor 1 | Rattus norvegicus (Norway rat) | IC50 | 0.0140 | 1 | 1 |
| Glutamate receptor 2 | Rattus norvegicus (Norway rat) | IC50 | 0.0140 | 1 | 1 |
| Glutamate receptor 3 | Rattus norvegicus (Norway rat) | IC50 | 0.0140 | 1 | 1 |
| Glutamate receptor 4 | Rattus norvegicus (Norway rat) | IC50 | 0.0140 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | IC50 | 51.5550 | 4 | 4 |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | IC50 | 52.7700 | 2 | 2 |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | IC50 | 3.1100 | 2 | 2 |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | IC50 | 52.7700 | 2 | 2 |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | IC50 | 5.5400 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | IC50 | 5.5400 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | IC50 | 5.5400 | 1 | 1 |
| Glutathione reductase | Plasmodium falciparum 3D7 | IC50 | 6.4000 | 1 | 1 |
| Glutathione reductase, mitochondrial | Homo sapiens (human) | IC50 | 16.2000 | 2 | 2 |
| Glycine N-methyltransferase | Homo sapiens (human) | IC50 | 316.0000 | 1 | 1 |
| GTPase KRas | Homo sapiens (human) | IC50 | 3.5800 | 1 | 1 |
| Heat sensitive channel TRPV3 | Rattus norvegicus (Norway rat) | IC50 | 0.7500 | 1 | 1 |
| Heat shock protein 75 kDa, mitochondrial | Homo sapiens (human) | IC50 | 0.6610 | 1 | 1 |
| Heat shock protein HSP 90 | Oryctolagus cuniculus (rabbit) | IC50 | 191.5705 | 2 | 4 |
| Heat shock protein HSP 90-alpha | Homo sapiens (human) | IC50 | 0.0917 | 20 | 20 |
| heat shock protein HSP 90-alpha isoform 2 | Homo sapiens (human) | IC50 | 50.0000 | 1 | 1 |
| Heat shock protein HSP 90-beta | Homo sapiens (human) | IC50 | 28.9608 | 7 | 8 |
| hepatocyte nuclear factor 4-alpha isoform 2 | Homo sapiens (human) | IC50 | 39.8690 | 1 | 1 |
| Hexose transporter 1 | Plasmodium falciparum (malaria parasite P. falciparum) | IC50 | 0.3260 | 1 | 1 |
| High affinity nerve growth factor receptor | Homo sapiens (human) | IC50 | 0.0095 | 3 | 3 |
| Histamine H3 receptor | Homo sapiens (human) | Ki | 3.1000 | 1 | 1 |
| Histone acetyltransferase KAT2B | Homo sapiens (human) | IC50 | 7.2000 | 1 | 1 |
| Histone deacetylase 1 | Homo sapiens (human) | IC50 | 71.0857 | 1 | 14 |
| Histone deacetylase 11 | Homo sapiens (human) | IC50 | 71.0857 | 1 | 14 |
| Histone deacetylase 2 | Homo sapiens (human) | IC50 | 71.0857 | 1 | 14 |
| Histone deacetylase 3 | Homo sapiens (human) | IC50 | 71.0857 | 1 | 14 |
| Histone deacetylase 4 | Homo sapiens (human) | IC50 | 71.0857 | 1 | 14 |
| Histone deacetylase 5 | Homo sapiens (human) | IC50 | 71.0857 | 1 | 14 |
| Histone deacetylase 6 | Homo sapiens (human) | IC50 | 71.0857 | 1 | 14 |
| Histone deacetylase 7 | Homo sapiens (human) | IC50 | 71.0857 | 1 | 14 |
| Histone deacetylase 8 | Homo sapiens (human) | IC50 | 71.0857 | 1 | 14 |
| Histone deacetylase 9 | Homo sapiens (human) | IC50 | 71.0857 | 1 | 14 |
| Histone-lysine N-methyltransferase EHMT1 | Homo sapiens (human) | IC50 | 180.5000 | 3 | 3 |
| Histone-lysine N-methyltransferase EHMT2 | Homo sapiens (human) | IC50 | 179.7333 | 3 | 3 |
| Histone-lysine N-methyltransferase SETD7 | Homo sapiens (human) | IC50 | 134.1667 | 3 | 3 |
| Histone-lysine N-methyltransferase, H3 lysine-79 specific | Homo sapiens (human) | IC50 | 33.7100 | 1 | 1 |
| Indoleamine 2,3-dioxygenase 1 | Homo sapiens (human) | IC50 | 0.7200 | 2 | 2 |
| Indolethylamine N-methyltransferase | Homo sapiens (human) | IC50 | 4.0000 | 1 | 1 |
| Induced myeloid leukemia cell differentiation protein Mcl-1 | Homo sapiens (human) | IC50 | 15.0200 | 3 | 5 |
| Induced myeloid leukemia cell differentiation protein Mcl-1 | Homo sapiens (human) | Ki | 2.7600 | 2 | 2 |
| Induced myeloid leukemia cell differentiation protein Mcl-1 homolog | Mus musculus (house mouse) | IC50 | 10.1000 | 3 | 3 |
| Inosine-5'-monophosphate dehydrogenase | Cryptococcus neoformans var. neoformans JEC21 | IC50 | 0.1200 | 1 | 1 |
| Inosine-5'-monophosphate dehydrogenase 1 | Homo sapiens (human) | IC50 | 3.3977 | 6 | 6 |
| Inosine-5'-monophosphate dehydrogenase 1 | Homo sapiens (human) | Ki | 0.0365 | 8 | 8 |
| Inosine-5'-monophosphate dehydrogenase 2 | Homo sapiens (human) | IC50 | 1.1421 | 20 | 20 |
| Inosine-5'-monophosphate dehydrogenase 2 | Homo sapiens (human) | Ki | 0.0084 | 8 | 8 |
| Insulin-degrading enzyme | Mus musculus (house mouse) | IC50 | 200.0000 | 1 | 1 |
| Integrase | Human immunodeficiency virus 1 | IC50 | 11.0250 | 12 | 12 |
| integrase, partial | Human immunodeficiency virus 1 | IC50 | 21.3142 | 2 | 4 |
| Isocitrate dehydrogenase [NADP] cytoplasmic | Homo sapiens (human) | Ki | 2.8500 | 1 | 1 |
| Kappa-type opioid receptor | Homo sapiens (human) | Ki | 2.3000 | 1 | 1 |
| kappa-type opioid receptor isoform 1 | Homo sapiens (human) | IC50 | 18.8950 | 2 | 2 |
| L-lactate dehydrogenase A chain | Homo sapiens (human) | Ki | 24.0000 | 1 | 1 |
| Lanosterol 14-alpha demethylase | Homo sapiens (human) | IC50 | 200.0000 | 1 | 1 |
| lens epithelium-derived growth factor p75 | Homo sapiens (human) | IC50 | 21.3142 | 2 | 4 |
| Lysine-specific demethylase 4B | Homo sapiens (human) | IC50 | 0.7000 | 1 | 1 |
| Lysine-specific demethylase 4C | Homo sapiens (human) | IC50 | 0.7000 | 1 | 1 |
| Lysine-specific demethylase 5A | Homo sapiens (human) | IC50 | 0.1300 | 1 | 1 |
| Lysine-specific demethylase 6B | Homo sapiens (human) | IC50 | 0.4000 | 1 | 1 |
| Lysine-specific histone demethylase 1A | Homo sapiens (human) | IC50 | 2.8100 | 1 | 1 |
| Lysosomal alpha-glucosidase | Homo sapiens (human) | IC50 | 5.7000 | 1 | 1 |
| Lysosomal alpha-glucosidase | Homo sapiens (human) | Ki | 7.3000 | 1 | 1 |
| M-phase inducer phosphatase 1 | Homo sapiens (human) | IC50 | 2.3000 | 1 | 1 |
| M-phase inducer phosphatase 2 | Homo sapiens (human) | IC50 | 46.8000 | 1 | 1 |
| Macrophage migration inhibitory factor | Homo sapiens (human) | IC50 | 0.6750 | 2 | 2 |
| Macrophage-expressed gene 1 protein | Homo sapiens (human) | IC50 | 0.2100 | 2 | 2 |
| Maltase-glucoamylase, intestinal | Homo sapiens (human) | IC50 | 5.7000 | 1 | 1 |
| Maltase-glucoamylase, intestinal | Homo sapiens (human) | Ki | 7.3000 | 1 | 1 |
| MAP/microtubule affinity-regulating kinase 4 | Homo sapiens (human) | IC50 | 1.7700 | 1 | 1 |
| MecA | Staphylococcus aureus | IC50 | 4.1667 | 3 | 3 |
| Metallo-beta-lactamase L1 type 3 | Stenotrophomonas maltophilia | IC50 | 2,100.0000 | 2 | 2 |
| Metallo-beta-lactamase type 2 | Bacillus cereus | IC50 | 200.0000 | 1 | 1 |
| Metallo-beta-lactamase type 2 | Bacteroides fragilis | IC50 | 2,260.0000 | 5 | 5 |
| Methionine aminopeptidase | Escherichia coli K-12 | IC50 | 100.0000 | 1 | 1 |
| Methionine aminopeptidase 1 | Homo sapiens (human) | IC50 | 15.0000 | 1 | 1 |
| Methionine aminopeptidase 1 | Saccharomyces cerevisiae S288C | IC50 | 100.0000 | 1 | 1 |
| Methionine aminopeptidase 2 | Homo sapiens (human) | IC50 | 0.0238 | 6 | 6 |
| Microtubule-associated protein tau | Homo sapiens (human) | IC50 | 9.4250 | 4 | 4 |
| Microtubule-associated proteins 1A/1B light chain 3A | Homo sapiens (human) | IC50 | 42.9000 | 1 | 1 |
| Microtubule-associated proteins 1A/1B light chain 3A | Homo sapiens (human) | Ki | 8.8000 | 1 | 1 |
| Microtubule-associated proteins 1A/1B light chain 3B | Homo sapiens (human) | IC50 | 172.0000 | 1 | 1 |
| Microtubule-associated proteins 1A/1B light chain 3B | Homo sapiens (human) | Ki | 19.3000 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase 10 | Homo sapiens (human) | IC50 | 0.0267 | 1 | 3 |
| Mitogen-activated protein kinase kinase kinase 11 | Homo sapiens (human) | IC50 | 0.0267 | 1 | 3 |
| Mitogen-activated protein kinase kinase kinase 9 | Homo sapiens (human) | IC50 | 0.0267 | 1 | 3 |
| MPI protein | Homo sapiens (human) | IC50 | 50.0000 | 1 | 1 |
| mRNA cap guanine-N7 methyltransferase | Homo sapiens (human) | IC50 | 0.0335 | 3 | 3 |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | IC50 | 0.5800 | 1 | 1 |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | IC50 | 6.0000 | 1 | 1 |
| Mu-type opioid receptor | Homo sapiens (human) | Ki | 1.3000 | 1 | 1 |
| Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | IC50 | 500.0000 | 1 | 1 |
| Multidrug resistance-associated protein 4 | Homo sapiens (human) | IC50 | 115.9929 | 1 | 14 |
| Myosin light chain kinase, smooth muscle | Gallus gallus (chicken) | IC50 | 0.0000 | 1 | 1 |
| Myosin light chain kinase, smooth muscle | Homo sapiens (human) | IC50 | 0.0220 | 1 | 1 |
| Myosin light chain kinase, smooth muscle | Homo sapiens (human) | Ki | 0.0200 | 1 | 1 |
| N-acylethanolamine-hydrolyzing acid amidase | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial | Bos taurus (cattle) | IC50 | 0.0050 | 1 | 1 |
| NADH-ubiquinone oxidoreductase chain 1 | Bos taurus (cattle) | IC50 | 0.0045 | 2 | 2 |
| neutrophil cytosol factor 1 | Homo sapiens (human) | IC50 | 0.3900 | 1 | 1 |
| Nicotinamide N-methyltransferase | Homo sapiens (human) | IC50 | 39.2367 | 3 | 3 |
| Nicotinate phosphoribosyltransferase | Homo sapiens (human) | Ki | 0.0003 | 1 | 1 |
| NLRP3 protein | Homo sapiens (human) | IC50 | 1.1475 | 2 | 2 |
| Non-structural protein 1 | Dengue virus | IC50 | 0.0410 | 1 | 1 |
| nonstructural protein 1 | Influenza A virus (A/California/07/2009(H1N1)) | IC50 | 4.7230 | 1 | 1 |
| NS5 | Zika virus | IC50 | 1.4000 | 2 | 2 |
| Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) | IC50 | 20.0000 | 1 | 1 |
| Orotidine 5'-phosphate decarboxylase | Methanothermobacter thermautotrophicus str. Delta H | Ki | 6.2000 | 1 | 1 |
| Peptidoglycan D,D-transpeptidase MrdA | Escherichia coli K-12 | IC50 | 0.5900 | 1 | 1 |
| perilipin-1 | Homo sapiens (human) | IC50 | 3.7080 | 1 | 1 |
| perilipin-5 | Homo sapiens (human) | IC50 | 4.5885 | 2 | 2 |
| Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | Ki | 5.6000 | 1 | 1 |
| Phosphoglycerate mutase 1 | Homo sapiens (human) | IC50 | 7.2000 | 1 | 1 |
| Phosphorylase b kinase gamma catalytic chain, liver/testis isoform | Homo sapiens (human) | IC50 | 0.0017 | 2 | 2 |
| Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | Homo sapiens (human) | IC50 | 0.0017 | 2 | 2 |
| Phosphorylase b kinase regulatory subunit alpha, liver isoform | Homo sapiens (human) | IC50 | 0.0017 | 2 | 2 |
| Phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform | Homo sapiens (human) | IC50 | 0.0017 | 2 | 2 |
| Phosphorylase b kinase regulatory subunit beta | Homo sapiens (human) | IC50 | 0.0017 | 2 | 2 |
| photoreceptor-specific nuclear receptor | Homo sapiens (human) | IC50 | 8.9620 | 1 | 1 |
| Polyamine deacetylase HDAC10 | Homo sapiens (human) | IC50 | 71.0857 | 1 | 14 |
| Polyphenol oxidase 2 | Agaricus bisporus | IC50 | 300.0000 | 2 | 2 |
| Polyunsaturated fatty acid 5-lipoxygenase | Homo sapiens (human) | IC50 | 1.2483 | 6 | 6 |
| Polyunsaturated fatty acid lipoxygenase ALOX12 | Homo sapiens (human) | IC50 | 0.5800 | 1 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Homo sapiens (human) | IC50 | 26.5500 | 2 | 2 |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | IC50 | 521.7345 | 10 | 16 |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | Ki | 100.0000 | 1 | 1 |
| Probable maltase-glucoamylase 2 | Homo sapiens (human) | IC50 | 5.7000 | 1 | 1 |
| Probable maltase-glucoamylase 2 | Homo sapiens (human) | Ki | 7.3000 | 1 | 1 |
| Prolyl 4-hydroxylase | Paramecium bursaria Chlorella virus 1 | IC50 | 212.6000 | 1 | 1 |
| Prostaglandin E synthase | Homo sapiens (human) | IC50 | 0.2000 | 1 | 1 |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | IC50 | 264.0000 | 1 | 2 |
| Prostaglandin G/H synthase 1 | Ovis aries (sheep) | IC50 | 18.9200 | 1 | 1 |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | IC50 | 1.9000 | 1 | 1 |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | Ki | 1.0000 | 1 | 1 |
| Protease | Human immunodeficiency virus 1 | IC50 | 2.5000 | 1 | 1 |
| Protease | Human immunodeficiency virus 1 | Ki | 0.0101 | 1 | 1 |
| Protein arginine N-methyltransferase 1 | Homo sapiens (human) | IC50 | 35.0000 | 3 | 3 |
| Protein arginine N-methyltransferase 5 | Homo sapiens (human) | IC50 | 182.8000 | 2 | 2 |
| Protein disulfide-isomerase | Homo sapiens (human) | Ki | 5.9000 | 1 | 1 |
| Protein farnesyltransferase subunit beta | Homo sapiens (human) | IC50 | 11.9000 | 1 | 1 |
| Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | Homo sapiens (human) | IC50 | 11.9000 | 1 | 1 |
| Protein kinase C alpha type | Homo sapiens (human) | IC50 | 0.2500 | 1 | 1 |
| Protein kinase C alpha type | Rattus norvegicus (Norway rat) | IC50 | 0.1250 | 2 | 2 |
| Protein kinase C beta type | Homo sapiens (human) | IC50 | 0.2500 | 1 | 1 |
| Protein kinase C beta type | Rattus norvegicus (Norway rat) | IC50 | 0.1250 | 2 | 2 |
| Protein kinase C delta type | Homo sapiens (human) | IC50 | 0.2500 | 1 | 1 |
| Protein kinase C delta type | Rattus norvegicus (Norway rat) | IC50 | 0.1250 | 2 | 2 |
| Protein kinase C epsilon type | Homo sapiens (human) | IC50 | 0.2500 | 1 | 1 |
| Protein kinase C epsilon type | Rattus norvegicus (Norway rat) | IC50 | 0.1250 | 2 | 2 |
| Protein kinase C eta type | Homo sapiens (human) | IC50 | 0.2500 | 1 | 1 |
| Protein kinase C eta type | Rattus norvegicus (Norway rat) | IC50 | 0.1250 | 2 | 2 |
| Protein kinase C gamma type | Homo sapiens (human) | IC50 | 0.2500 | 1 | 1 |
| Protein kinase C gamma type | Rattus norvegicus (Norway rat) | IC50 | 0.2400 | 3 | 3 |
| Protein kinase C iota type | Homo sapiens (human) | IC50 | 0.2500 | 1 | 1 |
| Protein kinase C theta type | Homo sapiens (human) | IC50 | 0.3900 | 2 | 2 |
| Protein kinase C theta type | Rattus norvegicus (Norway rat) | IC50 | 0.1250 | 2 | 2 |
| Protein kinase C zeta type | Homo sapiens (human) | IC50 | 0.2500 | 1 | 1 |
| Protein kinase C zeta type | Rattus norvegicus (Norway rat) | IC50 | 0.1250 | 2 | 2 |
| Protein-arginine deiminase type-1 | Homo sapiens (human) | IC50 | 48.3000 | 1 | 1 |
| Protein-arginine deiminase type-2 | Homo sapiens (human) | IC50 | 26.1000 | 1 | 1 |
| Protein-arginine deiminase type-3 | Homo sapiens (human) | IC50 | 0.4300 | 1 | 1 |
| Protein-arginine deiminase type-4 | Homo sapiens (human) | IC50 | 2,951.2500 | 3 | 4 |
| Protein-arginine deiminase type-4 | Homo sapiens (human) | Ki | 560.0000 | 1 | 1 |
| Protein-L-isoaspartate(D-aspartate) O-methyltransferase | Homo sapiens (human) | Ki | 86.5000 | 2 | 2 |
| Prothrombin | Homo sapiens (human) | Ki | 0.2240 | 1 | 1 |
| Proto-oncogene tyrosine-protein kinase Src | Homo sapiens (human) | IC50 | 40,000.0000 | 2 | 2 |
| Puromycin-sensitive aminopeptidase | Homo sapiens (human) | IC50 | 6.0750 | 2 | 2 |
| Putative heat shock protein HSP 90-alpha A4 | Homo sapiens (human) | IC50 | 0.1400 | 1 | 1 |
| Pyruvate kinase PKM | Homo sapiens (human) | IC50 | 53.0000 | 1 | 1 |
| rac GTPase-activating protein 1 isoform a | Homo sapiens (human) | IC50 | 30.3400 | 1 | 1 |
| receptor-interacting serine/threonine-protein kinase 2 isoform 1 | Homo sapiens (human) | IC50 | 28.1920 | 1 | 2 |
| Receptor-type tyrosine-protein kinase FLT3 | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Replicase polyprotein 1ab | Betacoronavirus England 1 | IC50 | 10.0000 | 1 | 1 |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | IC50 | 3.7766 | 6 | 7 |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | IC50 | 8.2627 | 2 | 3 |
| RNA guanine-N7 methyltransferase activating subunit | Homo sapiens (human) | IC50 | 0.3190 | 1 | 2 |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | Oryctolagus cuniculus (rabbit) | IC50 | 1,404.5000 | 2 | 2 |
| Secreted chorismate mutase | Mycobacterium tuberculosis H37Rv | IC50 | 1.0600 | 1 | 1 |
| Sentrin-specific protease 1 | Homo sapiens (human) | IC50 | 0.5200 | 2 | 2 |
| Sentrin-specific protease 2 | Homo sapiens (human) | IC50 | 6.9000 | 1 | 1 |
| Sentrin-specific protease 6 | Homo sapiens (human) | IC50 | 5.2000 | 1 | 1 |
| sentrin-specific protease 8 | Homo sapiens (human) | IC50 | 1.8500 | 2 | 2 |
| Serine palmitoyltransferase 2 | Homo sapiens (human) | IC50 | 0.0001 | 1 | 1 |
| Serine/threonine-protein kinase D1 | Homo sapiens (human) | IC50 | 0.2500 | 1 | 1 |
| Serine/threonine-protein kinase D3 | Homo sapiens (human) | IC50 | 0.2500 | 1 | 1 |
| Serine/threonine-protein kinase LMTK3 | Homo sapiens (human) | IC50 | 0.0794 | 1 | 1 |
| Serine/threonine-protein kinase pim-1 | Homo sapiens (human) | IC50 | 0.1500 | 1 | 1 |
| Serum paraoxonase/arylesterase 1 | Homo sapiens (human) | Ki | 9,193.0000 | 2 | 2 |
| Short transient receptor potential channel 5 | Homo sapiens (human) | IC50 | 0.4500 | 1 | 1 |
| Sialidase | Clostridium perfringens | IC50 | 12.2000 | 1 | 1 |
| Sialidase | Clostridium perfringens | Ki | 5.8000 | 1 | 1 |
| Sigma intracellular receptor 2 | Homo sapiens (human) | Ki | 3.4000 | 1 | 1 |
| Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | IC50 | 31.0000 | 1 | 1 |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | IC50 | 12.0000 | 1 | 1 |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | IC50 | 200.0000 | 1 | 1 |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | IC50 | 200.0000 | 1 | 1 |
| Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | IC50 | 0.0110 | 1 | 1 |
| Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | Ki | 0.0501 | 1 | 1 |
| Sodium/glucose cotransporter 1 | Homo sapiens (human) | IC50 | 18.7000 | 1 | 1 |
| Sodium/glucose cotransporter 2 | Homo sapiens (human) | IC50 | 4.1000 | 1 | 1 |
| Solute carrier family 15 member 1 | Homo sapiens (human) | Ki | 10,000.0000 | 2 | 2 |
| Solute carrier family 15 member 2 | Homo sapiens (human) | Ki | 8,308.8200 | 1 | 2 |
| Solute carrier family 15 member 2 | Rattus norvegicus (Norway rat) | Ki | 8,300.0000 | 1 | 1 |
| Solute carrier family 2, facilitated glucose transporter member 1 | Homo sapiens (human) | IC50 | 0.3210 | 1 | 1 |
| Solute carrier family 22 member 11 | Homo sapiens (human) | Ki | 0.2000 | 1 | 1 |
| Solute carrier family 22 member 6 | Homo sapiens (human) | Ki | 0.2200 | 1 | 1 |
| Solute carrier family 22 member 6 | Rattus norvegicus (Norway rat) | Ki | 284.0000 | 3 | 3 |
| Solute carrier family 22 member 7 | Homo sapiens (human) | IC50 | 1,410.0000 | 1 | 1 |
| Solute carrier family 22 member 7 | Rattus norvegicus (Norway rat) | IC50 | 1,500.0000 | 1 | 1 |
| Solute carrier family 22 member 8 | Mus musculus (house mouse) | IC50 | 33.3000 | 1 | 1 |
| Solute carrier family 22 member 8 | Homo sapiens (human) | Ki | 0.0400 | 1 | 1 |
| Solute carrier family 22 member 8 | Rattus norvegicus (Norway rat) | Ki | 48.0000 | 1 | 1 |
| Solute carrier organic anion transporter family member 1A1 | Rattus norvegicus (Norway rat) | Ki | 6.6000 | 1 | 1 |
| Solute carrier organic anion transporter family member 1A2 | Homo sapiens (human) | Ki | 11.0000 | 1 | 1 |
| Solute carrier organic anion transporter family member 1A4 | Rattus norvegicus (Norway rat) | Ki | 7.3000 | 1 | 1 |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | IC50 | 0.2300 | 1 | 1 |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | Ki | 2.0000 | 1 | 1 |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | Ki | 3.0000 | 1 | 1 |
| Solute carrier organic anion transporter family member 2B1 | Homo sapiens (human) | Ki | 3.0000 | 1 | 1 |
| Sphingomyelin phosphodiesterase | Bos taurus (cattle) | IC50 | 14.1000 | 1 | 1 |
| Sphingomyelin phosphodiesterase | Homo sapiens (human) | IC50 | 19.4200 | 2 | 2 |
| Spike glycoprotein | Severe acute respiratory syndrome coronavirus 2 | IC50 | 5.6000 | 1 | 1 |
| Steroid 17-alpha-hydroxylase/17,20 lyase | Rattus norvegicus (Norway rat) | Ki | 124.0000 | 1 | 1 |
| Sterol O-acyltransferase 1 | Homo sapiens (human) | IC50 | 50.0000 | 1 | 1 |
| Stimulator of interferon genes protein | Homo sapiens (human) | IC50 | 137.0000 | 1 | 1 |
| Sucrase-isomaltase, intestinal | Homo sapiens (human) | IC50 | 5.7000 | 1 | 1 |
| Sucrase-isomaltase, intestinal | Homo sapiens (human) | Ki | 7.3000 | 1 | 1 |
| Suppressor of tumorigenicity 14 protein | Homo sapiens (human) | Ki | 0.9240 | 1 | 1 |
| T-cell surface glycoprotein CD4 | Homo sapiens (human) | IC50 | 0.1300 | 1 | 1 |
| Tat | Human immunodeficiency virus 1 | IC50 | 42.1290 | 1 | 1 |
| Thioredoxin reductase | Entamoeba histolytica | Ki | 3.3000 | 1 | 1 |
| Thioredoxin reductase 1, cytoplasmic | Homo sapiens (human) | IC50 | 30.0000 | 1 | 1 |
| Thioredoxin reductase 1, cytoplasmic | Rattus norvegicus (Norway rat) | IC50 | 0.8100 | 3 | 3 |
| Thiosulfate sulfurtransferase | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| TPA: protein transporter TIM10 | Saccharomyces cerevisiae S288C | IC50 | 67.7500 | 2 | 2 |
| TPA: protein transporter TIM23 | Saccharomyces cerevisiae S288C | IC50 | 8.5600 | 1 | 1 |
| transactivating tegument protein VP16 [Human herpesvirus 1] | Human alphaherpesvirus 1 (Herpes simplex virus type 1) | IC50 | 6.3570 | 1 | 1 |
| Transcription factor p65 | Homo sapiens (human) | IC50 | 12.9500 | 2 | 2 |
| Transient receptor potential cation channel subfamily A member 1 | Rattus norvegicus (Norway rat) | IC50 | 43.1750 | 2 | 2 |
| Transient receptor potential cation channel subfamily M member 8 | Rattus norvegicus (Norway rat) | IC50 | 2.8000 | 1 | 1 |
| Transient receptor potential cation channel subfamily V member 1 | Homo sapiens (human) | IC50 | 3.7000 | 1 | 1 |
| Transient receptor potential cation channel subfamily V member 2 | Rattus norvegicus (Norway rat) | IC50 | 1.1000 | 1 | 1 |
| Transient receptor potential cation channel subfamily V member 4 | Rattus norvegicus (Norway rat) | IC50 | 5.9000 | 1 | 1 |
| Transporter | Rattus norvegicus (Norway rat) | Ki | 0.0158 | 1 | 1 |
| tRNA (cytosine(38)-C(5))-methyltransferase | Homo sapiens (human) | IC50 | 13.2000 | 1 | 1 |
| Tyrosine-protein kinase ABL1 | Homo sapiens (human) | IC50 | 3.0000 | 2 | 2 |
| Tyrosine-protein kinase Fyn | Homo sapiens (human) | IC50 | 5.1810 | 1 | 1 |
| Tyrosine-protein kinase Lck | Homo sapiens (human) | IC50 | 1.9230 | 1 | 1 |
| Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | IC50 | 5.5000 | 1 | 1 |
| Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | Ki | 3.2000 | 1 | 1 |
| Tyrosyl-DNA phosphodiesterase 1 | Homo sapiens (human) | IC50 | 18,000.0000 | 1 | 1 |
| UDP-3-O-acyl-N-acetylglucosamine deacetylase | Escherichia coli K-12 | IC50 | 0.0305 | 4 | 4 |
| UDP-3-O-acyl-N-acetylglucosamine deacetylase | Pseudomonas aeruginosa PAO1 | IC50 | 0.0788 | 4 | 4 |
| UDP-3-O-acyl-N-acetylglucosamine deacetylase | Escherichia coli K-12 | Ki | 0.0037 | 7 | 7 |
| UDP-3-O-acyl-N-acetylglucosamine deacetylase | Rhizobium leguminosarum bv. trifolii WSM1325 | Ki | 0.0032 | 2 | 2 |
| UDP-N-acetylglucosamine 1-carboxyvinyltransferase | Escherichia coli K-12 | IC50 | 3.5795 | 4 | 4 |
| UDP-N-acetylglucosamine 1-carboxyvinyltransferase | Pseudomonas aeruginosa PAO1 | IC50 | 10.5000 | 1 | 1 |
| Undecaprenyl-diphosphatase | Escherichia coli K-12 | IC50 | 5.6000 | 1 | 1 |
| Uridine 5'-monophosphate synthase | Homo sapiens (human) | Ki | 0.0170 | 1 | 1 |
| Urokinase-type plasminogen activator | Homo sapiens (human) | Ki | 14.4000 | 1 | 1 |
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | IC50 | 0.0430 | 2 | 2 |
| Vif | Human immunodeficiency virus 1 | IC50 | 28.6750 | 1 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | Homo sapiens (human) | IC50 | 177.9000 | 1 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | Homo sapiens (human) | IC50 | 177.9000 | 1 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | Homo sapiens (human) | IC50 | 177.9000 | 1 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | Homo sapiens (human) | IC50 | 177.9000 | 1 | 1 |
| Voltage-dependent T-type calcium channel subunit alpha-1G | Homo sapiens (human) | IC50 | 1.0000 | 1 | 1 |
| Voltage-dependent T-type calcium channel subunit alpha-1H | Homo sapiens (human) | IC50 | 1.0000 | 1 | 1 |
| Xanthine dehydrogenase/oxidase | Bos taurus (cattle) | IC50 | 31.6000 | 1 | 1 |
| Xanthine dehydrogenase/oxidase | Homo sapiens (human) | IC50 | 1.8000 | 1 | 1 |
| Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
|---|
| 1-deoxy-D-xylulose 5-phosphate reductoisomerase | Mycobacterium tuberculosis H37Rv | Kd | 0.0400 | 1 | 1 |
| 26S proteasome regulatory subunit 6B | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| 3-dehydroquinate dehydratase | Helicobacter pylori 26695 | Kd | 2.5000 | 1 | 1 |
| 3-dehydroquinate dehydratase | Streptomyces coelicolor A3(2) | Kd | 7.3000 | 1 | 1 |
| 5-hydroxytryptamine receptor 1A | Homo sapiens (human) | EC50 | 8.0000 | 1 | 1 |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | EC50 | 32.0000 | 1 | 1 |
| 5'-AMP-activated protein kinase catalytic subunit alpha-1 | Homo sapiens (human) | Kd | 0.4610 | 1 | 1 |
| 5'-AMP-activated protein kinase subunit gamma-1 | Homo sapiens (human) | Kd | 0.3520 | 1 | 1 |
| 5'-AMP-activated protein kinase subunit gamma-2 | Homo sapiens (human) | Kd | 0.8680 | 1 | 1 |
| AarF domain-containing protein kinase 1 | Homo sapiens (human) | Kd | 6.0900 | 1 | 1 |
| Actin-related protein 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Actin-related protein 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Activated CDC42 kinase 1 | Homo sapiens (human) | Kd | 1.7170 | 1 | 1 |
| Activin receptor type-1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Activin receptor type-1B | Homo sapiens (human) | Kd | 15.2580 | 1 | 1 |
| Activin receptor type-2B | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Acyl-CoA dehydrogenase family member 10 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Acyl-CoA dehydrogenase family member 11 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Adenosine kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Adenylate kinase 2, mitochondrial | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| ADP/ATP translocase 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| ADP/ATP translocase 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Albumin | Homo sapiens (human) | Kd | 12.0000 | 1 | 3 |
| ALK tyrosine kinase receptor | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | EC50 | 31.5000 | 1 | 1 |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | EC50 | 31.5000 | 1 | 1 |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | EC50 | 31.5000 | 1 | 1 |
| amino acid transporter AGP1 | Saccharomyces cerevisiae S288C | EC50 | 5.9800 | 1 | 1 |
| Angiotensin-converting enzyme 2 | Homo sapiens (human) | EC50 | 0.0965 | 1 | 2 |
| AP2-associated protein kinase 1 | Homo sapiens (human) | Kd | 0.0050 | 1 | 1 |
| ATP-dependent 6-phosphofructokinase, platelet type | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| ATP-dependent molecular chaperone HSP82 | Saccharomyces cerevisiae S288C | Kd | 1.2000 | 1 | 1 |
| ATP-dependent RNA helicase DDX1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| ATP-dependent RNA helicase DDX3X | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| ATP-dependent RNA helicase DDX42 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| ATP-dependent RNA helicase DHX30 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | Kd | 5.8884 | 1 | 1 |
| ATP-dependent translocase ABCB1 | Mus musculus (house mouse) | Kd | 5.9000 | 1 | 1 |
| Atypical kinase COQ8A, mitochondrial | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| Aurora kinase A | Homo sapiens (human) | Kd | 0.0200 | 1 | 1 |
| Aurora kinase B | Homo sapiens (human) | Kd | 0.3530 | 1 | 1 |
| B-cell lymphoma 6 protein | Homo sapiens (human) | Kd | 1,000.0000 | 1 | 1 |
| bcl-2-like protein 11 isoform 1 | Homo sapiens (human) | EC50 | 350.0000 | 1 | 2 |
| Beta-adrenergic receptor kinase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Beta-galactosidase | Escherichia coli | EC50 | 31.5000 | 1 | 1 |
| BMP-2-inducible protein kinase | Homo sapiens (human) | Kd | 0.0900 | 1 | 1 |
| Bone morphogenetic protein receptor type-1A | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Bone morphogenetic protein receptor type-1B | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Bone morphogenetic protein receptor type-2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Breakpoint cluster region protein | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Calcium/calmodulin-dependent protein kinase kinase 2 | Homo sapiens (human) | Kd | 2.2770 | 1 | 1 |
| Calcium/calmodulin-dependent protein kinase type II subunit delta | Homo sapiens (human) | Kd | 0.1900 | 1 | 1 |
| Calcium/calmodulin-dependent protein kinase type II subunit gamma | Homo sapiens (human) | Kd | 0.1730 | 1 | 1 |
| Calcium/calmodulin-dependent protein kinase type IV | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| cAMP-dependent protein kinase catalytic subunit alpha | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| cAMP-dependent protein kinase catalytic subunit beta | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| cAMP-dependent protein kinase catalytic subunit gamma | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| cAMP-dependent protein kinase type II-alpha regulatory subunit | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Cannabinoid receptor 2 | Homo sapiens (human) | EC50 | 0.1791 | 23 | 23 |
| Casein kinase I isoform alpha | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Casein kinase I isoform delta | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Casein kinase I isoform epsilon | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Casein kinase I isoform gamma-1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Casein kinase I isoform gamma-2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Casein kinase I isoform gamma-3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Casein kinase II subunit alpha' | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Caspase-1 | Homo sapiens (human) | Kd | 0.0188 | 1 | 1 |
| cGMP-dependent protein kinase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Chain A, ADENINE-N6-DNA-METHYLTRANSFERASE TAQI | Thermus aquaticus | Kd | 0.3400 | 1 | 2 |
| Chain A, BCL-2-RELATED PROTEIN A1 | Homo sapiens (human) | EC50 | 350.0000 | 1 | 2 |
| Chain A, Estrogen-related receptor gamma | Homo sapiens (human) | Kd | 0.7880 | 1 | 3 |
| Chain A, Gyrase | Escherichia coli | Kd | 1.2000 | 1 | 1 |
| Chain A, Hepatocyte growth factor receptor | Homo sapiens (human) | Kd | 0.0100 | 1 | 1 |
| Chain A, N5-carboxyaminoimidazole ribonucleotide mutase | Acetobacter aceti | Kd | 1,200.0000 | 1 | 4 |
| Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase | Pisum sativum (garden pea) | Kd | 4.2000 | 1 | 1 |
| Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase | Pisum sativum (garden pea) | Kd | 4.2000 | 1 | 3 |
| Chain B, ADENINE-N6-DNA-METHYLTRANSFERASE TAQI | Thermus aquaticus | Kd | 0.3400 | 1 | 1 |
| Chain B, N5-carboxyaminoimidazole ribonucleotide mutase | Acetobacter aceti | Kd | 1,200.0000 | 1 | 4 |
| Chromodomain-helicase-DNA-binding protein 4 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| citrate synthase 2, partial | Saccharomyces cerevisiae (brewer's yeast) | EC50 | 14,600.0000 | 1 | 2 |
| Citron Rho-interacting kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Cyclin-dependent kinase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Cyclin-dependent kinase 10 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Cyclin-dependent kinase 12 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Cyclin-dependent kinase 13 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Cyclin-dependent kinase 16 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Cyclin-dependent kinase 17 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Cyclin-dependent kinase 2 | Homo sapiens (human) | Kd | 0.1010 | 1 | 1 |
| Cyclin-dependent kinase 3 | Homo sapiens (human) | Kd | 0.0320 | 1 | 1 |
| Cyclin-dependent kinase 4 | Homo sapiens (human) | Kd | 0.0140 | 1 | 1 |
| Cyclin-dependent kinase 6 | Homo sapiens (human) | Kd | 0.3990 | 1 | 1 |
| Cyclin-dependent kinase 7 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Cyclin-dependent kinase 9 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Cyclin-dependent kinase-like 5 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Cyclin-dependent-like kinase 5 | Homo sapiens (human) | Kd | 0.9110 | 1 | 1 |
| Cyclin-G-associated kinase | Homo sapiens (human) | Kd | 1.2690 | 1 | 1 |
| Cytochrome c1, heme protein, mitochondrial | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| dCTP pyrophosphatase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| delta-type opioid receptor | Homo sapiens (human) | EC50 | 32.0000 | 1 | 1 |
| Delta(24)-sterol reductase | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Deoxycytidine kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Discoidin domain-containing receptor 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| DNA gyrase subunit B | Escherichia coli K-12 | Kd | 0.0175 | 2 | 2 |
| DNA polymerase alpha catalytic subunit | Homo sapiens (human) | EC50 | 2.0000 | 1 | 1 |
| DNA repair and recombination protein RAD54-like | Homo sapiens (human) | EC50 | 16.5000 | 1 | 1 |
| DNA replication licensing factor MCM4 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| DNA topoisomerase 2-alpha | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| DNA topoisomerase 2-beta | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| DnaJ homolog subfamily A member 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Dual specificity mitogen-activated protein kinase kinase 1 | Homo sapiens (human) | Kd | 1.7470 | 1 | 1 |
| Dual specificity mitogen-activated protein kinase kinase 2 | Homo sapiens (human) | Kd | 0.4740 | 1 | 1 |
| Dual specificity mitogen-activated protein kinase kinase 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Dual specificity mitogen-activated protein kinase kinase 4 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Dual specificity mitogen-activated protein kinase kinase 5 | Homo sapiens (human) | Kd | 2.0330 | 1 | 1 |
| Dual specificity mitogen-activated protein kinase kinase 6 | Homo sapiens (human) | Kd | 0.0880 | 1 | 1 |
| Dual specificity protein kinase CLK1 | Homo sapiens (human) | Kd | 0.0100 | 1 | 1 |
| Dual specificity protein kinase CLK2 | Homo sapiens (human) | Kd | 3.8090 | 1 | 1 |
| Dual specificity protein kinase CLK4 | Homo sapiens (human) | Kd | 0.0150 | 1 | 1 |
| Dual specificity protein kinase TTK | Homo sapiens (human) | Kd | 0.0300 | 1 | 1 |
| Dual specificity testis-specific protein kinase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Dual specificity testis-specific protein kinase 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Homo sapiens (human) | Kd | 4.8520 | 1 | 1 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1B | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Dynamin-like 120 kDa protein, mitochondrial | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| EKC/KEOPS complex subunit TP53RK | Homo sapiens (human) | Kd | 3.8400 | 1 | 1 |
| Electron transfer flavoprotein subunit beta | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Elongation factor Tu, mitochondrial | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| Ephrin type-A receptor 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Ephrin type-A receptor 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Ephrin type-A receptor 4 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Ephrin type-A receptor 5 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Ephrin type-A receptor 7 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Ephrin type-B receptor 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Ephrin type-B receptor 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Ephrin type-B receptor 4 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Ephrin type-B receptor 6 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Epidermal growth factor receptor | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Epithelial discoidin domain-containing receptor 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Estrogen receptor | Rattus norvegicus (Norway rat) | EC50 | 4.0180 | 1 | 2 |
| Estrogen receptor beta | Rattus norvegicus (Norway rat) | EC50 | 4.0180 | 1 | 2 |
| Eukaryotic translation initiation factor 2-alpha kinase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Eukaryotic translation initiation factor 5B | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Exosome RNA helicase MTR4 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Ferrochelatase, mitochondrial | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Fibroblast growth factor receptor 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Focal adhesion kinase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| G-protein coupled receptor 55 | Homo sapiens (human) | EC50 | 0.4450 | 1 | 1 |
| G-protein coupled receptor 84 | Homo sapiens (human) | EC50 | 2.0886 | 10 | 10 |
| General transcription and DNA repair factor IIH helicase subunit XPD | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Genome polyprotein | Zika virus | EC50 | 24.8000 | 1 | 1 |
| Glycine--tRNA ligase | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Glycogen phosphorylase, brain form | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Glycogen phosphorylase, liver form | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Glycogen synthase kinase-3 alpha | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Glycogen synthase kinase-3 beta | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| glycogen synthase kinase-3 beta isoform 1 | Homo sapiens (human) | EC50 | 300.0000 | 1 | 1 |
| GTP-binding nuclear protein Ran | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Heat sensitive channel TRPV3 | Rattus norvegicus (Norway rat) | EC50 | 0.5100 | 1 | 1 |
| heat shock protein 90 | Candida albicans | EC50 | 50.7207 | 1 | 3 |
| Heat shock protein 90, putative | Plasmodium falciparum 3D7 | Kd | 0.2435 | 2 | 2 |
| Heat shock protein HSP 90-alpha | Homo sapiens (human) | EC50 | 350.0175 | 2 | 2 |
| Heat shock protein HSP 90-alpha | Homo sapiens (human) | Kd | 84.1840 | 6 | 6 |
| Heat shock protein HSP 90-beta | Homo sapiens (human) | EC50 | 350.0175 | 2 | 2 |
| Heat shock protein HSP 90-beta | Homo sapiens (human) | Kd | 72.0543 | 7 | 7 |
| Heme oxygenase 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Hepatocyte growth factor receptor | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| High affinity nerve growth factor receptor | Homo sapiens (human) | Kd | 1.7390 | 1 | 1 |
| Hsf1 protein | Mus musculus (house mouse) | EC50 | 0.2430 | 1 | 1 |
| Inhibitor of nuclear factor kappa-B kinase subunit epsilon | Homo sapiens (human) | Kd | 0.4940 | 1 | 1 |
| Inosine-5'-monophosphate dehydrogenase 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Insulin receptor | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Insulin-like growth factor 1 receptor | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Integrin-linked protein kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Interleukin-1 receptor-associated kinase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Interleukin-1 receptor-associated kinase 3 | Homo sapiens (human) | Kd | 0.2540 | 1 | 1 |
| Interleukin-1 receptor-associated kinase 4 | Homo sapiens (human) | Kd | 0.0090 | 1 | 1 |
| Interstitial collagenase | Homo sapiens (human) | Kd | 21.7000 | 1 | 1 |
| LAP4 | Saccharomyces cerevisiae (brewer's yeast) | EC50 | 2.2287 | 2 | 4 |
| LIM domain kinase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| LIM domain kinase 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Long-chain-fatty-acid--CoA ligase 5 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Macrophage-stimulating protein receptor | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| MAP kinase-activated protein kinase 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| MAP kinase-activated protein kinase 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| MAP kinase-activated protein kinase 5 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| MAP/microtubule affinity-regulating kinase 3 | Homo sapiens (human) | Kd | 0.3840 | 1 | 1 |
| MAP/microtubule affinity-regulating kinase 4 | Homo sapiens (human) | Kd | 0.0280 | 1 | 1 |
| Maternal embryonic leucine zipper kinase | Homo sapiens (human) | Kd | 0.0830 | 1 | 1 |
| Membrane-associated progesterone receptor component 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| MEP2 | Saccharomyces cerevisiae (brewer's yeast) | EC50 | 337,300.0000 | 1 | 1 |
| Methionine--tRNA ligase, mitochondrial | Homo sapiens (human) | EC50 | 7.9000 | 1 | 1 |
| Microtubule-associated protein tau | Homo sapiens (human) | EC50 | 0.3600 | 2 | 2 |
| Microtubule-associated proteins 1A/1B light chain 3A | Homo sapiens (human) | Kd | 7.5000 | 1 | 1 |
| Microtubule-associated proteins 1A/1B light chain 3B | Homo sapiens (human) | Kd | 17.4000 | 1 | 1 |
| Midasin | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Misshapen-like kinase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mitogen-activated protein kinase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mitogen-activated protein kinase 10 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mitogen-activated protein kinase 11 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mitogen-activated protein kinase 14 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mitogen-activated protein kinase 15 | Homo sapiens (human) | Kd | 0.1670 | 1 | 1 |
| Mitogen-activated protein kinase 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mitogen-activated protein kinase 7 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mitogen-activated protein kinase 8 | Homo sapiens (human) | Kd | 0.5510 | 1 | 1 |
| Mitogen-activated protein kinase 9 | Homo sapiens (human) | Kd | 0.9860 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase 11 | Homo sapiens (human) | Kd | 0.5720 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase 2 | Homo sapiens (human) | Kd | 4.1180 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase 20 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase 4 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase 5 | Homo sapiens (human) | Kd | 0.1820 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase 6 | Homo sapiens (human) | Kd | 0.3350 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase kinase 1 | Homo sapiens (human) | Kd | 0.4520 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase kinase 2 | Homo sapiens (human) | Kd | 0.1310 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase kinase 3 | Homo sapiens (human) | Kd | 2.3740 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase kinase 4 | Homo sapiens (human) | Kd | 0.0190 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase kinase 5 | Homo sapiens (human) | Kd | 0.1930 | 1 | 1 |
| Mitotic checkpoint serine/threonine-protein kinase BUB1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| mu opioid receptor, partial | Homo sapiens (human) | EC50 | 32.0000 | 1 | 1 |
| Multidrug resistance protein MdtK | Escherichia coli K-12 | Kd | 90.9000 | 1 | 1 |
| Multifunctional protein ADE2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Myosin light chain kinase 3 | Homo sapiens (human) | Kd | 0.0980 | 1 | 1 |
| Myosin light chain kinase, smooth muscle | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Myosin-14 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Non-receptor tyrosine-protein kinase TNK1 | Homo sapiens (human) | Kd | 0.2870 | 1 | 1 |
| Non-receptor tyrosine-protein kinase TYK2 | Homo sapiens (human) | EC50 | 8.1200 | 1 | 2 |
| Non-receptor tyrosine-protein kinase TYK2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| NUAK family SNF1-like kinase 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Nuclear receptor subfamily 1 group I member 2 | Homo sapiens (human) | EC50 | 9.1200 | 5 | 5 |
| Nucleolar GTP-binding protein 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Oxysterols receptor LXR-alpha | Homo sapiens (human) | Kd | 3.2400 | 1 | 1 |
| Peroxiredoxin-1 | Homo sapiens (human) | Kd | 2.6100 | 1 | 1 |
| Peroxisomal acyl-coenzyme A oxidase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Peroxisomal acyl-coenzyme A oxidase 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | EC50 | 25.0000 | 1 | 1 |
| Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | Kd | 110.0000 | 1 | 1 |
| Phenylalanine--tRNA ligase beta subunit | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Phosphorylase b kinase gamma catalytic chain, liver/testis isoform | Homo sapiens (human) | Kd | 3.2630 | 1 | 1 |
| Platelet-derived growth factor receptor beta | Homo sapiens (human) | Kd | 1.0060 | 1 | 1 |
| POsterior Segregation | Caenorhabditis elegans | EC50 | 186.6810 | 1 | 1 |
| Probable ATP-dependent RNA helicase DDX6 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Procathepsin L | Homo sapiens (human) | EC50 | 0.0965 | 1 | 2 |
| Protease | Human immunodeficiency virus 1 | Kd | 0.5770 | 1 | 1 |
| Protein kinase C alpha type | Homo sapiens (human) | Kd | 2.2800 | 1 | 1 |
| Protein kinase C beta type | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Protein kinase C delta type | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| Protein kinase C iota type | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Protein kinase C theta type | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Protein kinase C zeta type | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Protein Rev | HIV-1 M:B_HXB2R | Kd | 4.1100 | 1 | 1 |
| Protein-tyrosine kinase 2-beta | Homo sapiens (human) | Kd | 1.3600 | 1 | 1 |
| Protein-tyrosine kinase 6 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Proto-oncogene tyrosine-protein kinase receptor Ret | Homo sapiens (human) | Kd | 0.6690 | 1 | 1 |
| Proto-oncogene tyrosine-protein kinase Src | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Putative heat shock protein HSP 90-beta 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| Pyridoxal kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Rab-like protein 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| RAC-alpha serine/threonine-protein kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| RAC-beta serine/threonine-protein kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| RAC-gamma serine/threonine-protein kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Ras-related protein Rab-10 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Ras-related protein Rab-27A | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Ras-related protein Rab-6A | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| Receptor-interacting serine/threonine-protein kinase 2 | Homo sapiens (human) | Kd | 0.5260 | 1 | 1 |
| Receptor-interacting serine/threonine-protein kinase 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Receptor-type tyrosine-protein kinase FLT3 | Homo sapiens (human) | Kd | 0.2270 | 1 | 1 |
| recombinase A | Mycobacterium tuberculosis H37Rv | EC50 | 49.1825 | 2 | 4 |
| Replicase polyprotein 1a | Severe acute respiratory syndrome-related coronavirus | EC50 | 0.0965 | 1 | 2 |
| Replicase polyprotein 1ab | Betacoronavirus England 1 | EC50 | 0.0965 | 1 | 2 |
| Replicase polyprotein 1ab | Human coronavirus 229E | EC50 | 0.0965 | 1 | 2 |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | EC50 | 0.0965 | 1 | 2 |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | EC50 | 0.0965 | 1 | 2 |
| Rho-associated protein kinase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Rho-associated protein kinase 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Ribosomal protein S6 kinase alpha-1 | Homo sapiens (human) | Kd | 2.9940 | 1 | 1 |
| Ribosomal protein S6 kinase alpha-3 | Homo sapiens (human) | Kd | 2.9900 | 1 | 1 |
| Ribosomal protein S6 kinase alpha-4 | Homo sapiens (human) | Kd | 0.4320 | 1 | 1 |
| Ribosomal protein S6 kinase alpha-5 | Homo sapiens (human) | Kd | 14.6590 | 1 | 1 |
| Ribosomal protein S6 kinase alpha-6 | Homo sapiens (human) | Kd | 2.1810 | 1 | 1 |
| Ribosomal protein S6 kinase beta-1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Ribosyldihydronicotinamide dehydrogenase [quinone] | Homo sapiens (human) | Kd | 4.0310 | 1 | 1 |
| RNA cytidine acetyltransferase | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| RPL19A | Saccharomyces cerevisiae (brewer's yeast) | EC50 | 25.3600 | 1 | 1 |
| S-adenosylmethionine synthase isoform type-2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Septin-9 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine palmitoyltransferase 1 | Homo sapiens (human) | EC50 | 0.0495 | 1 | 1 |
| Serine/threonine-protein kinase 10 | Homo sapiens (human) | Kd | 0.4810 | 1 | 1 |
| Serine/threonine-protein kinase 16 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase 24 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase 26 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase 3 | Homo sapiens (human) | Kd | 0.0430 | 1 | 1 |
| Serine/threonine-protein kinase 38 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase 38-like | Homo sapiens (human) | Kd | 2.1370 | 1 | 1 |
| Serine/threonine-protein kinase 4 | Homo sapiens (human) | Kd | 0.0290 | 1 | 1 |
| Serine/threonine-protein kinase A-Raf | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| Serine/threonine-protein kinase B-raf | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase Chk1 | Homo sapiens (human) | Kd | 0.1220 | 1 | 1 |
| Serine/threonine-protein kinase D2 | Homo sapiens (human) | Kd | 0.0300 | 1 | 1 |
| Serine/threonine-protein kinase D3 | Homo sapiens (human) | Kd | 0.0380 | 1 | 1 |
| Serine/threonine-protein kinase ICK | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase LATS1 | Homo sapiens (human) | Kd | 0.0670 | 1 | 1 |
| Serine/threonine-protein kinase MARK2 | Homo sapiens (human) | Kd | 0.7040 | 1 | 1 |
| Serine/threonine-protein kinase MRCK alpha | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase MRCK beta | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase MRCK gamma | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase N1 | Homo sapiens (human) | Kd | 0.2640 | 1 | 1 |
| Serine/threonine-protein kinase N2 | Homo sapiens (human) | Kd | 0.3610 | 1 | 1 |
| Serine/threonine-protein kinase N3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase Nek1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase Nek2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase Nek3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase Nek7 | Homo sapiens (human) | Kd | 0.0030 | 1 | 1 |
| Serine/threonine-protein kinase Nek9 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase NLK | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase PAK 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase PAK 4 | Homo sapiens (human) | Kd | 0.3440 | 1 | 1 |
| Serine/threonine-protein kinase PAK 6 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase pim-1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase pim-2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase PLK4 | Homo sapiens (human) | Kd | 0.0730 | 1 | 1 |
| Serine/threonine-protein kinase SIK2 | Homo sapiens (human) | Kd | 0.0580 | 1 | 1 |
| Serine/threonine-protein kinase SIK3 | Homo sapiens (human) | Kd | 4.0270 | 1 | 1 |
| Serine/threonine-protein kinase STK11 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase TAO1 | Homo sapiens (human) | Kd | 18.7570 | 1 | 1 |
| Serine/threonine-protein kinase TAO2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase TAO3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase TBK1 | Homo sapiens (human) | Kd | 1.1570 | 1 | 1 |
| Serine/threonine-protein kinase ULK1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase ULK3 | Homo sapiens (human) | Kd | 0.1070 | 1 | 1 |
| Serine/threonine-protein kinase/endoribonuclease IRE1 | Homo sapiens (human) | Kd | 0.0190 | 1 | 1 |
| Serine/threonine-protein kinase/endoribonuclease IRE2 | Homo sapiens (human) | Kd | 0.9080 | 1 | 1 |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | EC50 | 113.8860 | 1 | 1 |
| Spike glycoprotein | Betacoronavirus England 1 | EC50 | 0.0965 | 1 | 2 |
| Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | EC50 | 0.0965 | 1 | 2 |
| STE20-like serine/threonine-protein kinase | Homo sapiens (human) | Kd | 3.3050 | 1 | 1 |
| STE20-related kinase adapter protein alpha | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Stimulator of interferon genes protein | Homo sapiens (human) | Kd | 157.0000 | 1 | 1 |
| Stimulator of interferon genes protein | Mus musculus (house mouse) | Kd | 137.0000 | 1 | 1 |
| streptokinase A precursor | Streptococcus pyogenes M1 GAS | EC50 | 1.3796 | 2 | 7 |
| Structural maintenance of chromosomes protein 1A | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Structural maintenance of chromosomes protein 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| TGF-beta receptor type-1 | Homo sapiens (human) | Kd | 2.1790 | 1 | 1 |
| TGF-beta receptor type-2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Thiopurine S-methyltransferase | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
| Thyroid hormone receptor-associated protein 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| TRAF2 and NCK-interacting protein kinase | Homo sapiens (human) | Kd | 0.0100 | 1 | 1 |
| Transient receptor potential cation channel subfamily A member 1 | Homo sapiens (human) | EC50 | 8.8009 | 14 | 17 |
| Transient receptor potential cation channel subfamily A member 1 | Mus musculus (house mouse) | EC50 | 22.0000 | 1 | 1 |
| Transient receptor potential cation channel subfamily A member 1 | Rattus norvegicus (Norway rat) | EC50 | 2.1778 | 5 | 5 |
| Transient receptor potential cation channel subfamily M member 8 | Mus musculus (house mouse) | EC50 | 0.5000 | 1 | 1 |
| Transient receptor potential cation channel subfamily V member 1 | Homo sapiens (human) | EC50 | 82.0500 | 2 | 2 |
| Transient receptor potential cation channel subfamily V member 2 | Rattus norvegicus (Norway rat) | EC50 | 1.2000 | 1 | 1 |
| Transient receptor potential cation channel subfamily V member 4 | Rattus norvegicus (Norway rat) | EC50 | 0.9000 | 1 | 1 |
| Transmembrane protease serine 2 | Homo sapiens (human) | EC50 | 0.0965 | 1 | 2 |
| tRNA (cytosine(38)-C(5))-methyltransferase | Homo sapiens (human) | Kd | 7.5000 | 1 | 1 |
| Tyrosine--tRNA ligase, cytoplasmic | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Tyrosine-protein kinase ABL1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Tyrosine-protein kinase ABL2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Tyrosine-protein kinase BTK | Homo sapiens (human) | Kd | 1.5670 | 1 | 1 |
| Tyrosine-protein kinase CSK | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Tyrosine-protein kinase Fer | Homo sapiens (human) | Kd | 0.4550 | 1 | 1 |
| Tyrosine-protein kinase Fes/Fps | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Tyrosine-protein kinase FRK | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Tyrosine-protein kinase Fyn | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Tyrosine-protein kinase HCK | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Tyrosine-protein kinase JAK1 | Homo sapiens (human) | EC50 | 8.1200 | 1 | 2 |
| Tyrosine-protein kinase JAK1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Tyrosine-protein kinase Lck | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Tyrosine-protein kinase Lyn | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Tyrosine-protein kinase Mer | Homo sapiens (human) | Kd | 0.0410 | 1 | 1 |
| Tyrosine-protein kinase SYK | Homo sapiens (human) | Kd | 0.5450 | 1 | 1 |
| Tyrosine-protein kinase Tec | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Tyrosine-protein kinase Yes | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| U5 small nuclear ribonucleoprotein 200 kDa helicase | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| UDP-3-O-acyl-N-acetylglucosamine deacetylase | Pseudomonas aeruginosa PAO1 | Kd | 0.0005 | 1 | 1 |
| Uncharacterized aarF domain-containing protein kinase 5 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Uncharacterized protein FLJ45252 | Homo sapiens (human) | Kd | 0.0210 | 1 | 1 |
| Very long-chain specific acyl-CoA dehydrogenase, mitochondrial | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Wee1-like protein kinase | Homo sapiens (human) | Kd | 15.0007 | 2 | 2 |
| Zinc finger protein mex-5 | Caenorhabditis elegans | EC50 | 113.8860 | 1 | 1 |
| Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
|---|
| 30S ribosomal protein S1 | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| 30S ribosomal protein S10 | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| 30S ribosomal protein S11 | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| 30S ribosomal protein S12 | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| 30S ribosomal protein S13 | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| 30S ribosomal protein S14 | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| 30S ribosomal protein S15 | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| 30S ribosomal protein S16 | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| 30S ribosomal protein S17 | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| 30S ribosomal protein S18 | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| 30S ribosomal protein S19 | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| 30S ribosomal protein S2 | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| 30S ribosomal protein S20 | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| 30S ribosomal protein S21 | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| 30S ribosomal protein S3 | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| 30S ribosomal protein S4 | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| 30S ribosomal protein S5 | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| 30S ribosomal protein S6 | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| 30S ribosomal protein S7 | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| 30S ribosomal protein S8 | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| 30S ribosomal protein S9 | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| 50S ribosomal protein L1 | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| 50S ribosomal protein L10 | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| 50S ribosomal protein L11 | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| 50S ribosomal protein L13 | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| 50S ribosomal protein L14 | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| 50S ribosomal protein L15 | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| 50S ribosomal protein L16 | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| 50S ribosomal protein L17 | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| 50S ribosomal protein L18 | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| 50S ribosomal protein L19 | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| 50S ribosomal protein L2 | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| 50S ribosomal protein L20 | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| 50S ribosomal protein L21 | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| 50S ribosomal protein L22 | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| 50S ribosomal protein L23 | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| 50S ribosomal protein L24 | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| 50S ribosomal protein L25 | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| 50S ribosomal protein L27 | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| 50S ribosomal protein L28 | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| 50S ribosomal protein L29 | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| 50S ribosomal protein L3 | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| 50S ribosomal protein L30 | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| 50S ribosomal protein L31 | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| 50S ribosomal protein L31 type B | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| 50S ribosomal protein L32 | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| 50S ribosomal protein L33 | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| 50S ribosomal protein L34 | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| 50S ribosomal protein L35 | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| 50S ribosomal protein L36 | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| 50S ribosomal protein L36 2 | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| 50S ribosomal protein L4 | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| 50S ribosomal protein L5 | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| 50S ribosomal protein L6 | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| 50S ribosomal protein L7/L12 | Escherichia coli K-12 | Km | 234.0000 | 1 | 1 |
| Albumin | Bos taurus (cattle) | Kdiss | 2.9000 | 1 | 1 |
| Aminoglycoside 3'-phosphotransferase | Pseudomonas aeruginosa PAO1 | Km | 225.0000 | 1 | 2 |
| Androgen receptor | Homo sapiens (human) | EC150 | 633.0000 | 1 | 1 |
| ATP-citrate synthase | Rattus norvegicus (Norway rat) | Km | 110.0000 | 1 | 2 |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | Km | 1.0000 | 1 | 1 |
| B2 metallo-beta-lactamase | Chryseobacterium indologenes | Km | 60.0000 | 1 | 1 |
| Bcl-2-like protein 11 | Homo sapiens (human) | AC50 | 99.9300 | 1 | 1 |
| Beta-lactamase | Enterobacter cloacae | K | 5.1000 | 1 | 1 |
| Beta-lactamase | Enterobacter cloacae | Km | 71.2800 | 5 | 5 |
| Beta-lactamase | Morganella morganii | Km | 23.0000 | 1 | 1 |
| Beta-lactamase | Providencia stuartii | Km | 260.0000 | 1 | 1 |
| Beta-lactamase | Pseudomonas aeruginosa PAO1 | Km | 98.2000 | 5 | 5 |
| Beta-lactamase | Serratia marcescens | Km | 320.0000 | 1 | 1 |
| Beta-lactamase | Staphylococcus aureus | Km | 39.5000 | 2 | 2 |
| Beta-lactamase | Acinetobacter baumannii | Km | 165.0000 | 2 | 2 |
| Beta-lactamase | Acinetobacter pittii | Km | 98.0800 | 3 | 3 |
| Beta-lactamase | Aeromonas allosaccharophila | Km | 55.0000 | 1 | 1 |
| Beta-lactamase | Aeromonas caviae | Km | 76.0000 | 1 | 1 |
| Beta-lactamase | Burkholderia cenocepacia | Km | 100.0000 | 1 | 1 |
| Beta-lactamase | Citrobacter freundii | Km | 9.0000 | 1 | 1 |
| Beta-lactamase | Citrobacter gillenii | Km | 62.0000 | 1 | 1 |
| Beta-lactamase | Enterobacter cloacae | Km | 130.0000 | 1 | 1 |
| Beta-lactamase | Escherichia coli | Km | 109.7500 | 4 | 4 |
| Beta-lactamase | Klebsiella oxytoca | Km | 32.0000 | 1 | 1 |
| Beta-lactamase | Klebsiella pneumoniae | Km | 51.4667 | 3 | 3 |
| Beta-lactamase | Pseudomonas aeruginosa | Km | 109.5000 | 4 | 4 |
| Beta-lactamase | Pseudomonas luteola | Km | 21.0000 | 1 | 1 |
| Beta-lactamase | Salmonella enterica subsp. enterica serovar Westhampton | Km | 122.0000 | 1 | 1 |
| Beta-lactamase | Serratia fonticola | Km | 129.0000 | 1 | 1 |
| Beta-lactamase | Serratia marcescens | Km | 270.0000 | 1 | 1 |
| Beta-lactamase | Shouchella clausii | Km | 15.0000 | 1 | 1 |
| Beta-lactamase class B VIM-2 | Pseudomonas aeruginosa | Km | 310.6667 | 2 | 3 |
| Beta-lactamase OXA-1 | Escherichia coli | Kinact | 380.0000 | 1 | 1 |
| Beta-lactamase OXA-1 | Escherichia coli | Km | 10.0000 | 1 | 1 |
| Beta-lactamase SHV-1 | Escherichia coli | Km | 40.0000 | 1 | 1 |
| Beta-lactamase SHV-1 | Klebsiella pneumoniae | Km | 70.0000 | 3 | 3 |
| Beta-lactamase TEM | Escherichia coli | Km | 282.3333 | 3 | 3 |
| Beta-lactamase Toho-1 | Escherichia coli | Km | 190.0000 | 1 | 1 |
| Beta-lactamase VIM-1 | Pseudomonas aeruginosa | Km | 135.0000 | 1 | 1 |
| Cannabinoid receptor 1 | Homo sapiens (human) | Log Ki | 0.0036 | 1 | 1 |
| Cannabinoid receptor 2 | Homo sapiens (human) | Log Ki | 0.0035 | 1 | 1 |
| Carbapenem-hydrolyzing beta-lactamase KPC | Klebsiella pneumoniae | Km | 33.5000 | 2 | 2 |
| Carbonic anhydrase 1 | Homo sapiens (human) | Kinact | 6.6000 | 1 | 1 |
| Carbonic anhydrase 12 | Homo sapiens (human) | Kinact | 8.1000 | 1 | 1 |
| Carbonic anhydrase 13 | Mus musculus (house mouse) | Kinact | 4.9000 | 1 | 1 |
| Carbonic anhydrase 14 | Homo sapiens (human) | Kinact | 5.0000 | 1 | 1 |
| Carbonic anhydrase 2 | Homo sapiens (human) | Kinact | 6.5000 | 1 | 1 |
| Carbonic anhydrase 3 | Homo sapiens (human) | Kinact | 3.3000 | 1 | 1 |
| Carbonic anhydrase 4 | Homo sapiens (human) | Kinact | 5.4000 | 1 | 1 |
| Carbonic anhydrase 5A, mitochondrial | Homo sapiens (human) | Kinact | 8.3000 | 1 | 1 |
| Carbonic anhydrase 6 | Homo sapiens (human) | Kinact | 5.3000 | 1 | 1 |
| Carbonic anhydrase 7 | Homo sapiens (human) | Kinact | 16.0000 | 1 | 1 |
| Carbonic anhydrase 9 | Homo sapiens (human) | Kinact | 5.6000 | 1 | 1 |
| Caspase 6, apoptosis-related cysteine peptidase | Homo sapiens (human) | AC50 | 7.8400 | 1 | 3 |
| Cell death-related nuclease 4 | Caenorhabditis elegans | INH | 1,000.0000 | 1 | 1 |
| Cell division inhibitor SulA | Escherichia coli K-12 | Activity | 6.3000 | 1 | 1 |
| Chain A, BCL-2-RELATED PROTEIN A1 | Homo sapiens (human) | AC50 | 150.3397 | 3 | 3 |
| Dihydrolipoyl dehydrogenase | Plasmodium falciparum (malaria parasite P. falciparum) | Km | 49.0000 | 1 | 1 |
| Dihydrolipoyl dehydrogenase, mitochondrial | Sus scrofa (pig) | Km | 28.0000 | 1 | 1 |
| Dihydroxyacetone phosphate acyltransferase | Homo sapiens (human) | Radius of inhibition zone | 9,214.2857 | 7 | 7 |
| DNA gyrase subunit A | Escherichia coli K-12 | Activity | 9.1960 | 5 | 5 |
| DNA gyrase subunit A | Staphylococcus aureus | CC50 | 56.9500 | 3 | 6 |
| DNA gyrase subunit A | Escherichia coli K-12 | EC | 1.2000 | 1 | 1 |
| DNA gyrase subunit A | Staphylococcus aureus | MIC | 0.0100 | 1 | 1 |
| DNA gyrase subunit B | Escherichia coli K-12 | Activity | 0.4000 | 1 | 1 |
| DNA gyrase subunit B | Staphylococcus aureus | CC50 | 2.8500 | 1 | 2 |
| DNA gyrase subunit B | Escherichia coli K-12 | EC | 1.2000 | 1 | 1 |
| DNA gyrase subunit B | Staphylococcus aureus | MIC | 0.0100 | 1 | 1 |
| DNA repair protein RAD52 homolog isoform a | Homo sapiens (human) | AC50 | 0.9360 | 1 | 1 |
| DNA topoisomerase 2-alpha | Homo sapiens (human) | Activity | 104.0000 | 1 | 1 |
| DNA topoisomerase 2-alpha | Homo sapiens (human) | CC50 | 150.0000 | 1 | 2 |
| DNA topoisomerase 2-alpha | Homo sapiens (human) | EC2 | 150.0000 | 1 | 2 |
| DNA topoisomerase 4 subunit A | Staphylococcus aureus | CC50 | 0.3000 | 1 | 2 |
| DNA topoisomerase 4 subunit B | Staphylococcus aureus | CC50 | 0.3000 | 1 | 2 |
| Efflux transporter | Salmonella enterica subsp. enterica serovar Newport | Km | 5.1000 | 1 | 1 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | Mycobacterium tuberculosis H37Rv | MIC | 7.5700 | 2 | 3 |
| Flavodoxin | Helicobacter pylori 26695 | MIC | 67.3000 | 3 | 3 |
| GABA theta subunit | Rattus norvegicus (Norway rat) | Km | 9.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | Km | 9.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | Km | 9.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | Km | 9.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | Km | 9.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Rattus norvegicus (Norway rat) | Km | 9.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Rattus norvegicus (Norway rat) | Km | 9.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Rattus norvegicus (Norway rat) | Km | 9.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-2 | Rattus norvegicus (Norway rat) | Km | 9.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Rattus norvegicus (Norway rat) | Km | 9.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit delta | Rattus norvegicus (Norway rat) | Km | 9.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit epsilon | Rattus norvegicus (Norway rat) | Km | 9.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Rattus norvegicus (Norway rat) | Km | 9.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Rattus norvegicus (Norway rat) | Km | 9.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Rattus norvegicus (Norway rat) | Km | 9.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit pi | Rattus norvegicus (Norway rat) | Km | 9.0000 | 1 | 1 |
| Glucocorticoid receptor | Homo sapiens (human) | EC150 | 633.0000 | 1 | 1 |
| Glutathione reductase, mitochondrial | Homo sapiens (human) | Km | 6.3000 | 1 | 1 |
| glycogen synthase kinase-3 alpha | Homo sapiens (human) | AC50 | 1.9270 | 1 | 1 |
| heat shock protein 90, putative | Plasmodium falciparum 3D7 | AC50 | 1.1380 | 1 | 2 |
| Heat shock protein HSP 90-alpha | Homo sapiens (human) | Concentration | 5.0000 | 1 | 1 |
| heat shock protein HSP 90-alpha isoform 2 | Homo sapiens (human) | AC50 | 1.0770 | 1 | 2 |
| Heat shock protein HSP 90-beta | Homo sapiens (human) | Activity | 233.4437 | 3 | 3 |
| Histamine H3 receptor | Cavia porcellus (domestic guinea pig) | Km | 130.0000 | 1 | 1 |
| Hsf1 protein | Mus musculus (house mouse) | AC50 | 0.3610 | 3 | 3 |
| HSP40, subfamily A [Plasmodium falciparum 3D7] | Plasmodium falciparum 3D7 | AbsAC1000_uM | 0.6290 | 1 | 1 |
| Inosine-5'-monophosphate dehydrogenase | Cryptococcus neoformans var. neoformans JEC21 | Km | 87.1667 | 6 | 6 |
| interferon gamma precursor | Homo sapiens (human) | AC50 | 10.6418 | 2 | 4 |
| Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | Km | 62.0000 | 1 | 1 |
| Metallo-b-lactamase | Pseudomonas aeruginosa | Km | 1,772.5000 | 1 | 2 |
| Metallo-beta-lactamase | Escherichia coli | Km | 15.0000 | 4 | 4 |
| Metallo-beta-lactamase | Stutzerimonas stutzeri | Km | 6.0000 | 1 | 1 |
| Metallo-beta-lactamase type 2 | Klebsiella pneumoniae | Km | 10.0000 | 1 | 1 |
| Metallo-beta-lactamase VIM-11 | Pseudomonas aeruginosa | Km | 4.5000 | 1 | 1 |
| Metallo-beta-lactamase VIM-13 | Pseudomonas aeruginosa | Km | 76.0000 | 1 | 1 |
| Metallo-beta-lactamase VIM-2 | Klebsiella pneumoniae | Km | 44.0000 | 1 | 1 |
| Metallo-beta-lactamase VIM-2 | Pseudomonas aeruginosa | Km | 6.2000 | 1 | 1 |
| Microphthalmia-associated transcription factor | Homo sapiens (human) | AC50 | 35.0000 | 1 | 1 |
| MSH | Drosophila melanogaster (fruit fly) | AC50 | 48.6900 | 1 | 1 |
| PAX8 | Homo sapiens (human) | AC50 | 0.2600 | 1 | 1 |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | INH | 18.0000 | 1 | 1 |
| protein AF-9 isoform a | Homo sapiens (human) | AC50 | 4.0800 | 1 | 1 |
| replicative DNA helicase | Mycobacterium tuberculosis H37Rv | AC50 | 33.2288 | 2 | 4 |
| Ribonuclease T | Escherichia coli K-12 | INH | 1,000.0000 | 1 | 1 |
| Thioredoxin reductase 1, cytoplasmic | Homo sapiens (human) | Km | 95.0000 | 1 | 1 |
| Tissue factor | Homo sapiens (human) | Concentration | 5.0000 | 1 | 1 |
| Transient receptor potential cation channel subfamily A member 1 | Homo sapiens (human) | Activity | 10.0000 | 1 | 1 |
| twin arginine protein translocation system - TatA protein | Escherichia coli str. K-12 substr. MG1655 | AC50 | 3.8340 | 1 | 1 |
| UDP-3-O-acyl-N-acetylglucosamine deacetylase | Escherichia coli K-12 | Km | 7.5000 | 2 | 2 |
| UDP-3-O-acyl-N-acetylglucosamine deacetylase | Rhizobium leguminosarum bv. trifolii WSM1325 | Km | 6.9500 | 2 | 2 |
| UDP-glucuronosyltransferase 1A1 | Homo sapiens (human) | Km | 185.0000 | 1 | 1 |
| UDP-glucuronosyltransferase 1A10 | Homo sapiens (human) | Km | 76.5000 | 1 | 2 |
| UDP-glucuronosyltransferase 1A4 | Homo sapiens (human) | Km | 1,500.0000 | 1 | 1 |
| UDP-glucuronosyltransferase 1A7 | Homo sapiens (human) | Km | 30.0000 | 1 | 1 |
| UDP-glucuronosyltransferase 1A8 | Homo sapiens (human) | Km | 298.0000 | 1 | 1 |
| UDP-glucuronosyltransferase 1A9 | Homo sapiens (human) | Km | 225.5000 | 2 | 2 |
| UDP-glucuronosyltransferase 2B7 | Homo sapiens (human) | Km | 149.0000 | 1 | 1 |